This is a table of named entities, their types, and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel. Please keep in mind that named-entity extraction is not as accurate as more generic parts-of-speech extraction. Unusual results will appear here.
| entity | type | frequency |
|---|---|---|
| obesity | DISEASE | 1381 |
| covid | ORG | 718 |
| obesity | ORG | 349 |
| covid 19 | ORG | 279 |
| sars | DISEASE | 159 |
| inflammation | DISEASE | 158 |
| infection | DISEASE | 156 |
| individuals | TAXON | 138 |
| viral | TAXON | 131 |
| coronavirus | TAXON | 119 |
| diabetes | DISEASE | 107 |
| sars cov 2 | ORG | 97 |
| overweight | DISEASE | 93 |
| weight loss | DISEASE | 89 |
| virus | TAXON | 80 |
| type 2 diabetes | DISEASE | 73 |
| human | TAXON | 65 |
| mice | TAXON | 65 |
| cov | CHEMICAL | 62 |
| coronavirus disease | DISEASE | 59 |
| china | GPE | 58 |
| death | DISEASE | 57 |
| tnf | ORG | 55 |
| angiotensin | CHEMICAL | 54 |
| nafld | ORG | 47 |
| cvd | ORG | 43 |
| oxygen | CHEMICAL | 42 |
| adiponectin | PERSON | 41 |
| snap | ORG | 41 |
| obedis | ORG | 41 |
| coronavirus | TAXON | 37 |
| hypertension | DISEASE | 36 |
| h1n1 | GPE | 34 |
| pneumonia | DISEASE | 33 |
| cardiovascular disease | DISEASE | 33 |
| wuhan | GPE | 32 |
| cancer | DISEASE | 31 |
| weight gain | DISEASE | 28 |
| the united states | GPE | 28 |
| metabolic syndrome | DISEASE | 28 |
| il | ORG | 28 |
| humans | TAXON | 26 |
| glucose | CHEMICAL | 26 |
| diabetes | DISEASE | 26 |
| ons | ORG | 25 |
| raas | ORG | 24 |
| rna | ORG | 23 |
| acute respiratory syndrome coronavirus 2 sars cov | DISEASE | 22 |
| us | GPE | 22 |
| fibrosis | DISEASE | 22 |
| viral infections | DISEASE | 21 |
| viral infection | DISEASE | 21 |
| leptin | PERSON | 21 |
| infections | DISEASE | 21 |
| fatty liver disease | DISEASE | 21 |
| deaths | DISEASE | 20 |
| mouse | TAXON | 18 |
| t2d | ORG | 18 |
| nonalcoholic fatty liver disease | DISEASE | 17 |
| ncrnas | ORG | 17 |
| atherosclerosis | DISEASE | 17 |
| sars cov | ORG | 17 |
| hypoxia | DISEASE | 16 |
| copd | ORG | 16 |
| europe | LOC | 16 |
| bias | CHEMICAL | 16 |
| respiratory distress syndrome | DISEASE | 16 |
| sepsis | DISEASE | 16 |
| lung injury | DISEASE | 16 |
| heart failure | DISEASE | 15 |
| new york city | GPE | 15 |
| coronavirus disease | DISEASE | 15 |
| bmi | ORG | 15 |
| adipose | GPE | 15 |
| ee | CHEMICAL | 14 |
| overweight | DISEASE | 14 |
| icd | ORG | 14 |
| osa | ORG | 14 |
| italy | GPE | 14 |
| pa | ORG | 14 |
| animal | TAXON | 14 |
| vitamin d | CHEMICAL | 14 |
| critically ill | DISEASE | 14 |
| viruses | TAXON | 14 |
| ace 2 | ORG | 13 |
| human | TAXON | 13 |
| infection | DISEASE | 13 |
| uk | GPE | 13 |
| diabetic | DISEASE | 13 |
| thrombosis | DISEASE | 13 |
| respiratory failure | DISEASE | 12 |
| alcohol | CHEMICAL | 12 |
| t2dm | DISEASE | 12 |
| individuals | TAXON | 12 |
| viral | TAXON | 11 |
| virus | TAXON | 11 |
| diabetes mellitus | DISEASE | 11 |
| sb | CHEMICAL | 11 |
| prevalence | ORG | 11 |
| who | ORG | 11 |
| wat | ORG | 11 |
| metabolic disease | DISEASE | 11 |
| wic | ORG | 11 |
| hyperglycemia | DISEASE | 11 |
| iron | CHEMICAL | 11 |
| obese | DISEASE | 11 |
| metformin | CHEMICAL | 11 |
| angiotensin ii | CHEMICAL | 11 |
| angiotensin aldosterone | CHEMICAL | 10 |
| angiotensin | CHEMICAL | 10 |
| easo | ORG | 10 |
| usa | GPE | 10 |
| france | GPE | 10 |
| bacterial | TAXON | 10 |
| cholesterol | CHEMICAL | 10 |
| lipopolysaccharide | CHEMICAL | 10 |
| metabolic diseases | DISEASE | 10 |
| sodium | CHEMICAL | 9 |
| ncov | ORG | 9 |
| murine | TAXON | 9 |
| influenza | ORG | 9 |
| ci | ORG | 9 |
| ang ii | PERSON | 9 |
| inflammation | DISEASE | 8 |
| roux | ORG | 8 |
| new york | GPE | 8 |
| leptin | PERSON | 8 |
| cardiovascular diseases | DISEASE | 8 |
| glp1 | ORG | 8 |
| childhood | ORG | 8 |
| bariatric | GPE | 8 |
| united states | GPE | 8 |
| mice | TAXON | 8 |
| cirnas | ORG | 8 |
| hypoxemia | DISEASE | 8 |
| sarcopenia | GPE | 8 |
| respiratory diseases | DISEASE | 8 |
| myocardial infarction | DISEASE | 8 |
| coronavirus pneumonia | DISEASE | 8 |
| food insecurity | DISEASE | 8 |
| tumor necrosis | DISEASE | 8 |
| endothelial dysfunction | DISEASE | 8 |
| diseases | DISEASE | 8 |
| acute respiratory syndrome | DISEASE | 7 |
| ards | GPE | 7 |
| cm | ORG | 7 |
| crf | DISEASE | 7 |
| chronic | ORG | 7 |
| coronavirus disease | DISEASE | 7 |
| diet | ORG | 7 |
| hyperglycemia | PERSON | 7 |
| lps | ORG | 7 |
| vitamin d | PERSON | 7 |
| weight loss | DISEASE | 7 |
| rti | ORG | 7 |
| chronic disease | DISEASE | 7 |
| sleep apnea | DISEASE | 7 |
| chronic diseases | DISEASE | 7 |
| zinc | CHEMICAL | 7 |
| venous thromboembolism | DISEASE | 7 |
| steatohepatitis | DISEASE | 7 |
| statins | CHEMICAL | 7 |
| tocilizumab | CHEMICAL | 7 |
| orlistat | CHEMICAL | 7 |
| metabolic inflammation | DISEASE | 7 |
| hydroxychloroquine | CHEMICAL | 7 |
| chronic kidney disease | DISEASE | 7 |
| il 1 | ORG | 6 |
| saudi arabia | GPE | 6 |
| qol | PERSON | 6 |
| paris | GPE | 6 |
| outcomes | ORG | 6 |
| nash | ORG | 6 |
| mers | DISEASE | 6 |
| li | CHEMICAL | 6 |
| animal | TAXON | 6 |
| gm | ORG | 6 |
| epa | ORG | 6 |
| dha | CHEMICAL | 6 |
| california | GPE | 6 |
| cpt | ORG | 6 |
| ace inhibitors | CHEMICAL | 6 |
| treg | GPE | 6 |
| systematic | LOC | 6 |
| depression | DISEASE | 6 |
| wat browning | DISEASE | 6 |
| hyperglycaemia | DISEASE | 6 |
| animals | TAXON | 6 |
| respiratory syndrome coronavirus 2 sars | DISEASE | 6 |
| osteoarthritis | DISEASE | 6 |
| obesity obesity | DISEASE | 6 |
| nitric oxide | CHEMICAL | 6 |
| infectious disease | DISEASE | 6 |
| hyperinflammation | DISEASE | 6 |
| influenza virus infection | DISEASE | 6 |
| hypercytokinemia | DISEASE | 6 |
| coronary heart disease | DISEASE | 6 |
| anxiety | DISEASE | 6 |
| hepatic steatosis | DISEASE | 6 |
| comorbidity | DISEASE | 6 |
| asthma | DISEASE | 6 |
| dyslipidemia | DISEASE | 6 |
| ssbs | CHEMICAL | 5 |
| rosuvastatin | PERSON | 5 |
| imv | CHEMICAL | 5 |
| rbp | ORG | 5 |
| psm | ORG | 5 |
| n ob | ORG | 5 |
| mycobacterium | TAXON | 5 |
| k | CHEMICAL | 5 |
| india | GPE | 5 |
| iga | ORG | 5 |
| dxa | ORG | 5 |
| il 6 | ORG | 5 |
| iii | ORG | 5 |
| ii | ORG | 5 |
| ifn | ORG | 5 |
| hydroxychloroquine | CHEMICAL | 5 |
| hco | ORG | 5 |
| h1n1 infection | DISEASE | 5 |
| anril | ORG | 5 |
| vd | ORG | 5 |
| sepsis | DISEASE | 5 |
| vascular disease | DISEASE | 5 |
| weight loss | DISEASE | 5 |
| liraglutide | CHEMICAL | 5 |
| zhang et al | PERSON | 5 |
| vivo | GPE | 5 |
| thrombotic | DISEASE | 5 |
| smoking | CHEMICAL | 5 |
| pain | DISEASE | 5 |
| overweight obesity | DISEASE | 5 |
| nucleotides | CHEMICAL | 5 |
| microbiome | TAXON | 5 |
| metabolic disorders | DISEASE | 5 |
| rheumatoid arthritis | DISEASE | 5 |
| hypovitaminosis d | CHEMICAL | 5 |
| hyperinsulinemia | DISEASE | 5 |
| fructose | CHEMICAL | 5 |
| eating behavior | DISEASE | 5 |
| comorbid | DISEASE | 5 |
| anemia | ORG | 5 |
| alveolar damage | DISEASE | 5 |
| hypertension diabetes | DISEASE | 5 |
| acute lung injury | DISEASE | 5 |
| meta | ORG | 4 |
| ecg | ORG | 4 |
| h1n1 disease | DISEASE | 4 |
| h1n1 influenza | PERSON | 4 |
| icd10 | CHEMICAL | 4 |
| mers cov | ORG | 4 |
| no | CHEMICAL | 4 |
| mouse | TAXON | 4 |
| myplate | PERSON | 4 |
| nfl | ORG | 4 |
| nonalcoholic fatty liver disease | DISEASE | 4 |
| obesity hypoventilation syndrome | DISEASE | 4 |
| diabetic | DISEASE | 4 |
| dietary | PERSON | 4 |
| adiponectin | GPE | 4 |
| diarem | CHEMICAL | 4 |
| dss | CHEMICAL | 4 |
| covid 19 | ORG | 4 |
| chloroquine | CHEMICAL | 4 |
| cardiovascular | GPE | 4 |
| bic | ORG | 4 |
| angiotensin aldosterone | CHEMICAL | 4 |
| alligier | ORG | 4 |
| adiposity | ORG | 4 |
| adipocyte | PERSON | 4 |
| arb | ORG | 4 |
| 5795 | DISEASE | 4 |
| pge2 | PERSON | 4 |
| obstructive sleep apnea | DISEASE | 4 |
| brazil | GPE | 4 |
| peru | GPE | 4 |
| illness | DISEASE | 4 |
| tissue damage | DISEASE | 4 |
| respiratory syndrome | DISEASE | 4 |
| respiratory infections | DISEASE | 4 |
| respiratory disease | DISEASE | 4 |
| rats | TAXON | 4 |
| pulmonary embolism | DISEASE | 4 |
| metabolic derangement | DISEASE | 4 |
| leukotrienes | CHEMICAL | 4 |
| pneumonia | GPE | 4 |
| influenza | ORG | 4 |
| infectious diseases | DISEASE | 4 |
| infection obesity | DISEASE | 4 |
| infected | DISEASE | 4 |
| type 2 diabetes mellitus | DISEASE | 4 |
| hypertrophy | DISEASE | 4 |
| chloroquine | CHEMICAL | 4 |
| fatty acids | CHEMICAL | 4 |
| sab | ORG | 4 |
| seattle | GPE | 4 |
| tocilizumab | ORG | 4 |
| cardiac dysfunction | DISEASE | 4 |
| ymca | ORG | 4 |
| coronavirus infection | DISEASE | 4 |
| coronavirus infections | DISEASE | 4 |
| diabetes obesity | DISEASE | 4 |
| endotoxemia | DISEASE | 4 |
| fatty acid | CHEMICAL | 4 |
| massachusetts | GPE | 3 |
| nafld nash | ORG | 3 |
| mortality | DISEASE | 3 |
| mexico | GPE | 3 |
| mechanisms | PERSON | 3 |
| maternal | ORG | 3 |
| kaplan meier | ORG | 3 |
| mafld | ORG | 3 |
| liver disease | DISEASE | 3 |
| liraglutide | ORG | 3 |
| kurbo | GPE | 3 |
| kingdom | GPE | 3 |
| na | CHEMICAL | 3 |
| nod | ORG | 3 |
| risk | PERSON | 3 |
| ob | ORG | 3 |
| pge | CHEMICAL | 3 |
| pok | GPE | 3 |
| rdn | ORG | 3 |
| results | ORG | 3 |
| sc | LOC | 3 |
| sl | ORG | 3 |
| sendai | ORG | 3 |
| shenzhen | GPE | 3 |
| south korea | GPE | 3 |
| steatosis | GPE | 3 |
| t1d | DISEASE | 3 |
| jak | ORG | 3 |
| jak2 | CHEMICAL | 3 |
| covid19 | ORG | 3 |
| iran | GPE | 3 |
| healthcare | ORG | 3 |
| ap hp | ORG | 3 |
| arbs | CHEMICAL | 3 |
| asj | ORG | 3 |
| american heart association | ORG | 3 |
| associations | ORG | 3 |
| atherosclerosis | GPE | 3 |
| bia | ORG | 3 |
| bmr | ORG | 3 |
| caat | ORG | 3 |
| cc | CHEMICAL | 3 |
| cd4 | GPE | 3 |
| cdr1as | PERSON | 3 |
| chims | DISEASE | 3 |
| coronado | ORG | 3 |
| u s | ORG | 3 |
| cancer | ORG | 3 |
| cardiovascular disease | DISEASE | 3 |
| circular | ORG | 3 |
| dgas | CHEMICAL | 3 |
| dm | ORG | 3 |
| diabetes mellitus | DISEASE | 3 |
| ehr | ORG | 3 |
| epidemic | DISEASE | 3 |
| glucagon | PERSON | 3 |
| glucose | CHEMICAL | 3 |
| h1n1 obesity | PERSON | 3 |
| hfd | ORG | 3 |
| the european association for the study of obesity | ORG | 3 |
| lipid | GPE | 3 |
| washington state | GPE | 3 |
| prediabetes | DISEASE | 3 |
| kidney disease | DISEASE | 3 |
| liver disease | DISEASE | 3 |
| loss of oro naso sensory ons | DISEASE | 3 |
| malnutrition | DISEASE | 3 |
| mammalian | TAXON | 3 |
| mammals | TAXON | 3 |
| metabolic complications | DISEASE | 3 |
| obesity hypertension | DISEASE | 3 |
| obesity hypoventilation syndrome | DISEASE | 3 |
| obstructive sleep apnea osa | DISEASE | 3 |
| organ failure | DISEASE | 3 |
| pigs | TAXON | 3 |
| plants | TAXON | 3 |
| prostaglandins | CHEMICAL | 3 |
| intravascular coagulation | DISEASE | 3 |
| respiratory disorders | DISEASE | 3 |
| the u s | GPE | 3 |
| the united kingdom | GPE | 3 |
| the world health organization | ORG | 3 |
| thromboembolism | DISEASE | 3 |
| vascular dysfunction | DISEASE | 3 |
| ventilation obesity | DISEASE | 3 |
| viral pneumonia | DISEASE | 3 |
| virus infection | DISEASE | 3 |
| vitamin e | CHEMICAL | 3 |
| vitamins | CHEMICAL | 3 |
| vitro | GPE | 3 |
| weight gain | DISEASE | 3 |
| joint pain | DISEASE | 3 |
| sarcopenic obesity | DISEASE | 3 |
| infectious | DISEASE | 3 |
| chronic heart failure | DISEASE | 3 |
| world health organization | ORG | 3 |
| human infection | DISEASE | 3 |
| world health organization who | ORG | 3 |
| abdominal obesity | DISEASE | 3 |
| acute respiratory syndrome coronavirus 2 infection | DISEASE | 3 |
| amino acid | CHEMICAL | 3 |
| anakinra | CHEMICAL | 3 |
| apolipoprotein e | DISEASE | 3 |
| app | ORG | 3 |
| arterial stiffness | DISEASE | 3 |
| autoimmune disease | DISEASE | 3 |
| cardiometabolic disease | DISEASE | 3 |
| cardiovascular | ORG | 3 |
| anosmia | DISEASE | 3 |
| chronic obstructive pulmonary disease | DISEASE | 3 |
| diet | ORG | 3 |
| gut microbiota | PERSON | 3 |
| circnrxn2 | ORG | 3 |
| fever | DISEASE | 3 |
| endotheliitis | DISEASE | 3 |
| dyspnea | DISEASE | 3 |
| eating disorder | DISEASE | 3 |
| cough | DISEASE | 3 |
| corona virus disease | DISEASE | 3 |
| coagulopathy | DISEASE | 3 |
| circrnas | ORG | 3 |
| human cells | TAXON | 3 |
| nadph | ORG | 2 |
| obes facts | ORG | 2 |
| nb | ORG | 2 |
| nfs | ORG | 2 |
| nephrolithiasis | GPE | 2 |
| new mexico | GPE | 2 |
| n 8112 | ORG | 2 |
| nonalcoholic steatohepatitis | DISEASE | 2 |
| outcomes in patients with covid 19 | ORG | 2 |
| obesity increases mortality and modulates the lung metabolome | ORG | 2 |
| obesity obesity | DISEASE | 2 |
| observational routinely | ORG | 2 |
| orlistat | ORG | 2 |
| pediatric weight management evidence based guidelines | ORG | 2 |
| peres karina | PERSON | 2 |
| petrilli | CHEMICAL | 2 |
| myd88 | ORG | 2 |
| perivascular | ORG | 2 |
| mycobacterium tuberculosis | CHEMICAL | 2 |
| later adiposity inflammation | ORG | 2 |
| morbidity | ORG | 2 |
| middle east | LOC | 2 |
| krela | CHEMICAL | 2 |
| possibly | ORG | 2 |
| krela kaźmierczak | PERSON | 2 |
| ldh | ORG | 2 |
| loinc | ORG | 2 |
| lady michelle | PERSON | 2 |
| lifestyle | ORG | 2 |
| lille | GPE | 2 |
| lille intensive care covid 19 | ORG | 2 |
| mas | ORG | 2 |
| mist | ORG | 2 |
| mnt | ORG | 2 |
| makkah | TAXON | 2 |
| marco | CHEMICAL | 2 |
| maximal | ORG | 2 |
| metabolic syndrome | DISEASE | 2 |
| microbes | TAXON | 2 |
| pol ii | PERSON | 2 |
| trl | ORG | 2 |
| presenting characteristics comorbidities | ORG | 2 |
| singapore | GPE | 2 |
| socioeconomic | GPE | 2 |
| soremartec italy | LOC | 2 |
| success | ORG | 2 |
| supertracker | ORG | 2 |
| sébastien | CHEMICAL | 2 |
| t cell dysfunction | DISEASE | 2 |
| thp | CHEMICAL | 2 |
| tsh | ORG | 2 |
| tappy | CHEMICAL | 2 |
| ultra | ORG | 2 |
| telemedicine | PERSON | 2 |
| the academy of nutrition and dietetics | ORG | 2 |
| type 2 diabetes | DISEASE | 2 |
| type 2 diabetes | DISEASE | 2 |
| usda | ORG | 2 |
| usfda | ORG | 2 |
| jiangsu province | GPE | 2 |
| social | PERSON | 2 |
| simvastatin | PERSON | 2 |
| prolonged | ORG | 2 |
| shenzhen obesity | DISEASE | 2 |
| pubmed | LOC | 2 |
| rantes | ORG | 2 |
| rd | ORG | 2 |
| rakhee yadav | PERSON | 2 |
| renin angiotensin aldosterone system | PERSON | 2 |
| respiratory distress syndrome | DISEASE | 2 |
| respiratory syndrome coronavirus 2 sars | DISEASE | 2 |
| sars cov 1 | ORG | 2 |
| sars cov infection | DISEASE | 2 |
| sars infection | DISEASE | 2 |
| sglt | ORG | 2 |
| sr | ORG | 2 |
| sarcopenia | GPE | 2 |
| school breakfast program | ORG | 2 |
| semaglutide | ORG | 2 |
| sendai virus | TAXON | 2 |
| shea | PERSON | 2 |
| klebsiella | PERSON | 2 |
| amp | ORG | 2 |
| influenza virus infection | DISEASE | 2 |
| bonferroni | PERSON | 2 |
| cbt | ORG | 2 |
| cd4 t | ORG | 2 |
| cd8 | ORG | 2 |
| cdc | DISEASE | 2 |
| co2 | PERSON | 2 |
| cov | ORG | 2 |
| covid 19 3 | ORG | 2 |
| covid 19 association | ORG | 2 |
| covid 19 coronavirus disease | DISEASE | 2 |
| cpap | ORG | 2 |
| crp | ORG | 2 |
| canada | GPE | 2 |
| characteristics | ORG | 2 |
| circslnn | ORG | 2 |
| city | DISEASE | 2 |
| coagulopathy | PERSON | 2 |
| considerations | ORG | 2 |
| buffalo bubalus | PERSON | 2 |
| biobank | GPE | 2 |
| infection multiple potential mechanisms | ORG | 2 |
| bifidobacterium | LOC | 2 |
| vte | ORG | 2 |
| 140 | DISEASE | 2 |
| 325055 | CHEMICAL | 2 |
| aap | ORG | 2 |
| acei | ORG | 2 |
| adp | ORG | 2 |
| aiims | ORG | 2 |
| adipocytokines | CHEMICAL | 2 |
| adult care food program | ORG | 2 |
| alcohol | CHEMICAL | 2 |
| apoe | GPE | 2 |
| arcinas | GPE | 2 |
| association of blood glucose control | ORG | 2 |
| bmi despite bmi | ORG | 2 |
| bod pod | ORG | 2 |
| barak obama | PERSON | 2 |
| berlin | GPE | 2 |
| consume | ORG | 2 |
| cotran | GPE | 2 |
| curr probl pediatr | ORG | 2 |
| cytokine amplification | ORG | 2 |
| gwas | ORG | 2 |
| gender | PERSON | 2 |
| germany | GPE | 2 |
| global | ORG | 2 |
| gut microbiota | PERSON | 2 |
| h5n1 virus | TAXON | 2 |
| hdhl | CHEMICAL | 2 |
| hdlcholesterol | ORG | 2 |
| hhs | ORG | 2 |
| hlh | DISEASE | 2 |
| hebebrand | GPE | 2 |
| hong kong | GPE | 2 |
| hyperinsulinemia | PERSON | 2 |
| hypertension | DISEASE | 2 |
| hypoxaemia | ORG | 2 |
| icd10 insertion of endotracheal airway | ORG | 2 |
| iqr | ORG | 2 |
| glp 1ra | ORG | 2 |
| glp | ORG | 2 |
| frühbeck gema | PERSON | 2 |
| editor obesity | DISEASE | 2 |
| dbt | CHEMICAL | 2 |
| dea jv | ORG | 2 |
| dhd | ORG | 2 |
| doi | ORG | 2 |
| dpp | ORG | 2 |
| diabetter | PERSON | 2 |
| eoss | ORG | 2 |
| edmonton obesity staging system | ORG | 2 |
| fibrosis | DISEASE | 2 |
| england | GPE | 2 |
| epidemiological | ORG | 2 |
| euan | CHEMICAL | 2 |
| european association for the study of obesity position | ORG | 2 |
| figo | ORG | 2 |
| fasn | ORG | 2 |
| fatty acids | CHEMICAL | 2 |
| united states obesity | ORG | 2 |
| nhs | ORG | 2 |
| viral infections | DISEASE | 2 |
| olfactory dysfunction | DISEASE | 2 |
| omentin ghrelin | CHEMICAL | 2 |
| organ damage | DISEASE | 2 |
| overweight decreases | DISEASE | 2 |
| pancreatic damage | DISEASE | 2 |
| pathologies | DISEASE | 2 |
| pipeline | CHEMICAL | 2 |
| progesterone | CHEMICAL | 2 |
| prostacyclin | GPE | 2 |
| pulmonary fibrosis | DISEASE | 2 |
| pulmonary infection | DISEASE | 2 |
| pulmonary inflammation | DISEASE | 2 |
| pulmonary lipofibroblasts | DISEASE | 2 |
| pyruvate | CHEMICAL | 2 |
| quinoa | PERSON | 2 |
| rat | TAXON | 2 |
| respiratory distress | DISEASE | 2 |
| respiratory syndrome coronavirus | DISEASE | 2 |
| omega 3 fatty acids | CHEMICAL | 2 |
| obstructive sleep apnea syndrome | DISEASE | 2 |
| rodent | TAXON | 2 |
| obstructive sleep apnea | DISEASE | 2 |
| metabolic and cardiovascular disease | DISEASE | 2 |
| mirna | ORG | 2 |
| mice transgenic | TAXON | 2 |
| microbiota | TAXON | 2 |
| microvascular | GPE | 2 |
| microvascular dysfunction | DISEASE | 2 |
| microvascular or macrovascular complications | DISEASE | 2 |
| mmhg | ORG | 2 |
| multiorgan failure | DISEASE | 2 |
| myocarditis | DISEASE | 2 |
| ncov obesity | ORG | 2 |
| neoplasia | DISEASE | 2 |
| neutrophil | GPE | 2 |
| nutritional deficiencies | DISEASE | 2 |
| obesity a | DISEASE | 2 |
| obesity covid | DISEASE | 2 |
| obesity diabetes | DISEASE | 2 |
| rhinosinusitis | DISEASE | 2 |
| rodents | TAXON | 2 |
| man | TAXON | 2 |
| tissue injury | DISEASE | 2 |
| type 2 diabetes t2d | DISEASE | 2 |
| unopposed | CHEMICAL | 2 |
| vascular congestion | DISEASE | 2 |
| viral rna | TAXON | 2 |
| viral contagion | DISEASE | 2 |
| visceral obesity | DISEASE | 2 |
| visfatin | CHEMICAL | 2 |
| vitamin | CHEMICAL | 2 |
| vitamin a | CHEMICAL | 2 |
| vitamin d deficiency | CHEMICAL | 2 |
| weight gain inflammation | DISEASE | 2 |
| weight reduction | DISEASE | 2 |
| weight stigma | DISEASE | 2 |
| wellcontrolled | DISEASE | 2 |
| white adipose browning | DISEASE | 2 |
| viroporin 3a | CHEMICAL | 2 |
| yiiz9s53 | DISEASE | 2 |
| triglyceride | CHEMICAL | 2 |
| the upper airways | ORG | 2 |
| saturated fatty acids | CHEMICAL | 2 |
| the association of bmi | ORG | 2 |
| saxagliptin | PERSON | 2 |
| shock | DISEASE | 2 |
| simvastatin | CHEMICAL | 2 |
| sitagliptin vildagliptin | GPE | 2 |
| sleep disorders | DISEASE | 2 |
| smoking diabetes hypertension | DISEASE | 2 |
| statin | CHEMICAL | 2 |
| stroke | DISEASE | 2 |
| substance abuse | DISEASE | 2 |
| sugars | CHEMICAL | 2 |
| taste dysfunction | DISEASE | 2 |
| the american medical association | ORG | 2 |
| the american society for metabolic and bariatric surgery s | ORG | 2 |
| the european association for the study of obesity obesity | ORG | 2 |
| the national school lunch program nslp | ORG | 2 |
| the ordinal scale for clinical improvement world health organization | ORG | 2 |
| the task force on childhood obesity | ORG | 2 |
| metabolic abnormalities | DISEASE | 2 |
| type 1 diabetes | DISEASE | 2 |
| lymphopenia | DISEASE | 2 |
| apnea hypopnea | DISEASE | 2 |
| atherosclerotic lesions | DISEASE | 2 |
| atrial fibrillation | DISEASE | 2 |
| bacterial infections | DISEASE | 2 |
| breast milk | DISEASE | 2 |
| calcium | CHEMICAL | 2 |
| capillary congestion | DISEASE | 2 |
| carbohydrate | CHEMICAL | 2 |
| carbohydrates | CHEMICAL | 2 |
| carbon dioxide | CHEMICAL | 2 |
| cardiometabolic diseases | DISEASE | 2 |
| cardiomyopathy | DISEASE | 2 |
| cardiovascular death | DISEASE | 2 |
| chronic obstructive pulmonary disease copd | DISEASE | 2 |
| coagulation obesity | DISEASE | 2 |
| colchicine | CHEMICAL | 2 |
| conflict | DISEASE | 2 |
| crescimento | GPE | 2 |
| aspirin | CHEMICAL | 2 |
| angiotensinaldosterone | CHEMICAL | 2 |
| diabetes hypertension | DISEASE | 2 |
| aldosterone | CHEMICAL | 2 |
| vitamin d vd | PERSON | 2 |
| lung dysfunctions | DISEASE | 2 |
| visceral | ORG | 2 |
| vitamin d deficiency | CHEMICAL | 2 |
| womac | ORG | 2 |
| warburg | GPE | 2 |
| wnt | PERSON | 2 |
| wuhan presenting characteristics comorbidities | ORG | 2 |
| acute diabetes | DISEASE | 2 |
| acute kidney injury | DISEASE | 2 |
| acute respiratory distress syndrome | DISEASE | 2 |
| acute respiratory distress syndrome obesity | DISEASE | 2 |
| acute respiratory infection | DISEASE | 2 |
| adenovirus | TAXON | 2 |
| adipose inflammation | DISEASE | 2 |
| airway inflammation | DISEASE | 2 |
| alcoholic steatohepatitis | DISEASE | 2 |
| dexamethasone | CHEMICAL | 2 |
| acute metabolic decompensation | DISEASE | 2 |
| diabetes mellitus dm | DISEASE | 2 |
| human genes | TAXON | 2 |
| hyperinflammatory syndrome | DISEASE | 2 |
| hypertensive | DISEASE | 2 |
| hyperuricemia | DISEASE | 2 |
| hypoadiponectinemia | DISEASE | 2 |
| hypoxic respiratory failure | DISEASE | 2 |
| immune dysfunction infection | DISEASE | 2 |
| immunologic dysfunction | DISEASE | 2 |
| influenza a h1n1 infection | DISEASE | 2 |
| influenza infection | DISEASE | 2 |
| interferon gamma | CHEMICAL | 2 |
| intestinal obstruction | DISEASE | 2 |
| journal | ORG | 2 |
| lipopolysaccharide lps | TAXON | 2 |
| loss of taste and smell | DISEASE | 2 |
| dietary behaviors | DISEASE | 2 |
| liver failure | DISEASE | 2 |
| loss of olfactory sensory | DISEASE | 2 |
| hydroxy chloroquine | CHEMICAL | 2 |
| intestinal dysbiosis | DISEASE | 2 |
| human coronavirus | TAXON | 2 |
| goblet cell hyperplasia squamous metaplasia | DISEASE | 2 |
| gastric tumor | DISEASE | 2 |
| human adipocytes | TAXON | 2 |
| failure | DISEASE | 2 |
| ghrelin | CHEMICAL | 2 |
| glomerulopathy | DISEASE | 2 |
| eating disorders | DISEASE | 2 |
| glucose intolerance | DISEASE | 2 |
| glycemia | DISEASE | 2 |
| glioblastoma | DISEASE | 2 |
| fatty acids ffas | CHEMICAL | 2 |
| hsa_circh19 | CHEMICAL | 2 |
| hemophagocytic lymphohistiocytosis | DISEASE | 2 |
| heparin | CHEMICAL | 2 |
| hepatocellular carcinoma | DISEASE | 2 |
| hosts | TAXON | 2 |
| green foods | CHEMICAL | 2 |
| nct04288713 | CHEMICAL | 1 |
| ncd | ORG | 1 |
| nash nonalcoholic steatohepatitis nafld nonalcoholic fatty liver disease | DISEASE | 1 |
| n ob 71 | ORG | 1 |
| nash cirrhosis | DISEASE | 1 |
| nafld steatohepatitis | DISEASE | 1 |
| nacb lmpg committee | ORG | 1 |
| nafld promotion | ORG | 1 |
| nafld nonalcoholic | ORG | 1 |
| nafld nafld | ORG | 1 |
| nafl | DISEASE | 1 |
| ndf | CHEMICAL | 1 |
| n18 | ORG | 1 |
| nafld nash progress to date effects | ORG | 1 |
| nannipieri monica | PERSON | 1 |
| ndf rt therapeutic classes lab | ORG | 1 |
| nkt | ORG | 1 |
| nova | ORG | 1 |
| nps | CHEMICAL | 1 |
| nsw | ORG | 1 |
| nasopharyngeal | ORG | 1 |
| nathalie j | PERSON | 1 |
| nathalie j frühbeck gema goossens | PERSON | 1 |
| national academy of clinical biochemistry | ORG | 1 |
| national food security | ORG | 1 |
| national football league | ORG | 1 |
| myofibroblast | LOC | 1 |
| national health commission guidelines | ORG | 1 |
| native | ORG | 1 |
| national health systems | ORG | 1 |
| n a | CHEMICAL | 1 |
| molecular | GPE | 1 |
| myocardial infarction | DISEASE | 1 |
| mobile | GPE | 1 |
| mexico chile | GPE | 1 |
| mice genetic | TAXON | 1 |
| neck circumference | PERSON | 1 |
| mice impact of obesity | ORG | 1 |
| mice metabolic | LOC | 1 |
| microangiopathy | TAXON | 1 |
| microbiome | TAXON | 1 |
| microvascular | ORG | 1 |
| mifflin jeor | PERSON | 1 |
| mikael scheen | PERSON | 1 |
| mingrone | CHEMICAL | 1 |
| minimal | PERSON | 1 |
| ministry of health | ORG | 1 |
| misconceptions | PERSON | 1 |
| mohammad pakhchanian haig raiker | PERSON | 1 |
| mygoodlife | PERSON | 1 |
| molina molina et al | PERSON | 1 |
| monica nannipieri | PERSON | 1 |
| monocyte macrophage drive chronic inflammation and impair wound healing in diabetes mellitus upregulation | ORG | 1 |
| morbid | PERSON | 1 |
| morbid obesity | DISEASE | 1 |
| morbid obesity | DISEASE | 1 |
| moriconi diego | PERSON | 1 |
| mullerova e | CHEMICAL | 1 |
| multivariate | ORG | 1 |
| musculoskeletal | ORG | 1 |
| myplatemywins | CHEMICAL | 1 |
| mypyramid | ORG | 1 |
| mycobacterium tuberculosis infection | CHEMICAL | 1 |
| myeloid | DISEASE | 1 |
| natural language processing data | ORG | 1 |
| obese patients specificities and management influenza | ORG | 1 |
| neck surg | PERSON | 1 |
| obesity stigma | DISEASE | 1 |
| obese children with sepsis | ORG | 1 |
| obese patients | ORG | 1 |
| obesity a | DISEASE | 1 |
| obesity covid | DISEASE | 1 |
| obesity covid 19 | ORG | 1 |
| obesity ecpo | DISEASE | 1 |
| obesity impairs the adaptive immune response | ORG | 1 |
| obesity increases the duration of influenza a virus shedding | ORG | 1 |
| obesity its odd relationship | ORG | 1 |
| obesity prevalence of obesity among adults | ORG | 1 |
| obesity silver spring obesity | ORG | 1 |
| obesity cardiomyopathy | DISEASE | 1 |
| obesity heart failure | DISEASE | 1 |
| obesity osteoarthritis | DISEASE | 1 |
| observational | PERSON | 1 |
| obes rev | ORG | 1 |
| observational health data sciences | ORG | 1 |
| observational study of hydroxychloroquine in hospitalized patients | ORG | 1 |
| office | ORG | 1 |
| olbers | CHEMICAL | 1 |
| olfaction under metabolic influences alterations | ORG | 1 |
| olfactory and gustatory dysfunctions | DISEASE | 1 |
| omentin a | PERSON | 1 |
| organ dysfunction | DISEASE | 1 |
| osteoarthritis | DISEASE | 1 |
| other mrnas encoding | ORG | 1 |
| otolaryngol head | PERSON | 1 |
| outcome | ORG | 1 |
| metropolitan | GPE | 1 |
| overall | ORG | 1 |
| obese | GPE | 1 |
| osa obesity hypoventilation syndrome | DISEASE | 1 |
| neck surg smell | PERSON | 1 |
| nonalcoholic fatty liver disease | CHEMICAL | 1 |
| neovius martin | PERSON | 1 |
| nestlé ag | ORG | 1 |
| neurodegenerative disease | DISEASE | 1 |
| neurological dysfunction | DISEASE | 1 |
| new onset | GPE | 1 |
| new york city european association | GPE | 1 |
| new york city factors | GPE | 1 |
| new york city intensive care | GPE | 1 |
| new york city obesity | GPE | 1 |
| nogueira | CHEMICAL | 1 |
| nogueira de almeida | PERSON | 1 |
| non | PERSON | 1 |
| non alcoholic steatohepatitis | ORG | 1 |
| nonadipose | PERSON | 1 |
| nonalcoholic steatohepatitis a review effect of body mass index metabolic health | ORG | 1 |
| omop | ORG | 1 |
| norfolk | ORG | 1 |
| norfolk ffq | PERSON | 1 |
| normal | LOC | 1 |
| northern italy | LOC | 1 |
| notably eculizumab | PERSON | 1 |
| noteworthy | ORG | 1 |
| nutrients | ORG | 1 |
| nutritional health of participants implications for future research | ORG | 1 |
| nutrição e sistema imune | CHEMICAL | 1 |
| o rahilly | ORG | 1 |
| o2 | CHEMICAL | 1 |
| obedis core variables project | ORG | 1 |
| obedis core variables project european expert guidelines on a minimal core set of variables | ORG | 1 |
| obedis obesity | ORG | 1 |
| mexico centres for disease control and prevention overweight | ORG | 1 |
| laparoscopic | ORG | 1 |
| metformin | CHEMICAL | 1 |
| lv | ORG | 1 |
| korakas | ORG | 1 |
| korea angiotensin | ORG | 1 |
| korean society for the study of obesity guideline for the management of obesity | ORG | 1 |
| kountouri aikaterini raptis athanasios palaiodimou | ORG | 1 |
| kousathana foteini | PERSON | 1 |
| kurbo ww | PERSON | 1 |
| kyung | PERSON | 1 |
| l chandrasekaran | PERSON | 1 |
| l chandrasekaran suchi | CHEMICAL | 1 |
| lc | PERSON | 1 |
| lh | ORG | 1 |
| linc | ORG | 1 |
| linc pint long intergenic non protein coding rna p53 induced transcript | ORG | 1 |
| lnc | ORG | 1 |
| lv diastolic dysfunction | DISEASE | 1 |
| khan amira sayed | PERSON | 1 |
| la red ili 002 | ORG | 1 |
| laiwu | PERSON | 1 |
| laiwu pigs | TAXON | 1 |
| pa pa | ORG | 1 |
| laparoscopic roux | PERSON | 1 |
| latino | PERSON | 1 |
| laville martine | PERSON | 1 |
| legislation | PERSON | 1 |
| length | PERSON | 1 |
| leptin hyperleptinemia | PERSON | 1 |
| lerman a | PERSON | 1 |
| lessons | ORG | 1 |
| lighter | ORG | 1 |
| lim soo shin | PERSON | 1 |
| killer | PERSON | 1 |
| kaufman | PERSON | 1 |
| lipopolysaccharide | CHEMICAL | 1 |
| jens christian lehtinen | PERSON | 1 |
| interventions sharing | ORG | 1 |
| intracellular | ORG | 1 |
| iron | ORG | 1 |
| italian health institute | ORG | 1 |
| italy spain | GPE | 1 |
| itrim | ORG | 1 |
| j bouwman k clément | ORG | 1 |
| j c holm | ORG | 1 |
| jak2 inhibitor baricitinib | ORG | 1 |
| jped | ORG | 1 |
| janus | GPE | 1 |
| jean luc katsahian | PERSON | 1 |
| jean michel pagotto | PERSON | 1 |
| jean sébastien poghosyan tigran carette | PERSON | 1 |
| jiangsu | GPE | 1 |
| kass | PERSON | 1 |
| jiangsu china | LOC | 1 |
| jildau brunault | PERSON | 1 |
| jorg halford jason | PERSON | 1 |
| josep alberti george amiel stephanie | PERSON | 1 |
| juliana ning guang raz itamar | PERSON | 1 |
| juonala | GPE | 1 |
| k clément | ORG | 1 |
| klf7 | PERSON | 1 |
| kp | CHEMICAL | 1 |
| ksrp | PERSON | 1 |
| kachikis alisa | CHEMICAL | 1 |
| kalligeros et al | PERSON | 1 |
| kanakadurga | PERSON | 1 |
| karine | CHEMICAL | 1 |
| lina kokkinos | PERSON | 1 |
| lipotoxic damage | DISEASE | 1 |
| metabolic dysfunction | DISEASE | 1 |
| mechanically | PERSON | 1 |
| macrophage | ORG | 1 |
| madinah | ORG | 1 |
| maine | GPE | 1 |
| malnutrition | DISEASE | 1 |
| mammalian | TAXON | 1 |
| manca maria laura | PERSON | 1 |
| mann whitney u | PERSON | 1 |
| marcin d amato gabriele portincasa piero title | CHEMICAL | 1 |
| marcio josé | CHEMICAL | 1 |
| maria felicia | PERSON | 1 |
| maria laura manca | PERSON | 1 |
| martin | ORG | 1 |
| mccartney stephen | PERSON | 1 |
| mcmaster universities womac va | ORG | 1 |
| med doi | PERSON | 1 |
| macartney coxson | PERSON | 1 |
| med hypotheses accepted | ORG | 1 |
| medical management total | ORG | 1 |
| medical unit | ORG | 1 |
| medications | ORG | 1 |
| medrxiv | GPE | 1 |
| mellitus | ORG | 1 |
| menopause | DISEASE | 1 |
| mesurer la subjectivité | PERSON | 1 |
| meta analysis association | ORG | 1 |
| metab res rev | PERSON | 1 |
| metab syndr influenza | ORG | 1 |
| metabolic dysfunction | DISEASE | 1 |
| metabolic inflammation | DISEASE | 1 |
| metabolic syndrome | DISEASE | 1 |
| macronutrient mediated inflammation and oxidative stress relevance to insulin resistance obesity | ORG | 1 |
| mac os | PERSON | 1 |
| lipowska | GPE | 1 |
| loss of taste | DISEASE | 1 |
| listeria monocytogenes | TAXON | 1 |
| liu | PERSON | 1 |
| liu x et al | PERSON | 1 |
| liver | LOC | 1 |
| liver fibrosis | ORG | 1 |
| lockhart | PERSON | 1 |
| lockhart sam m | PERSON | 1 |
| lokken | CHEMICAL | 1 |
| lombardy | GPE | 1 |
| lombardy icu network baseline characteristics | ORG | 1 |
| longgen | CHEMICAL | 1 |
| los angeles | GPE | 1 |
| loss | PERSON | 1 |
| loss of smell and taste | DISEASE | 1 |
| low vitamin d | PERSON | 1 |
| myc | ORG | 1 |
| luc yki järvinen hannele ziegler | PERSON | 1 |
| lucas leite | ORG | 1 |
| luis alberto | PERSON | 1 |
| m neovius | PERSON | 1 |
| m1 | ORG | 1 |
| masp 2 | ORG | 1 |
| mers cov defective | ORG | 1 |
| mers cov infection | DISEASE | 1 |
| mice | ORG | 1 |
| mip | ORG | 1 |
| mip 1a | CHEMICAL | 1 |
| mof | ORG | 1 |
| mof ly6c hi | CHEMICAL | 1 |
| moh | ORG | 1 |
| overweight world health organization coronavirus | ORG | 1 |
| rachel l | PERSON | 1 |
| pa this | ORG | 1 |
| syndr | TAXON | 1 |
| statins | CHEMICAL | 1 |
| stefano | PERSON | 1 |
| stephanie feinstein ronald fisher martin | ORG | 1 |
| stephen | GPE | 1 |
| studies | ORG | 1 |
| study group underweight | ORG | 1 |
| suchi adams waldorf kristina m | PERSON | 1 |
| sudden | GPE | 1 |
| sugar | PERSON | 1 |
| supplementary material kp | ORG | 1 |
| susanna mullerova dana | PERSON | 1 |
| sweden | GPE | 1 |
| switzerland | GPE | 1 |
| symptoms obesity impairs the adaptive immune response | ORG | 1 |
| t cell dysfunction obesity | DISEASE | 1 |
| states clinical | ORG | 1 |
| t title obesity | DISEASE | 1 |
| t2d 140 | DISEASE | 1 |
| t2d obesity | DISEASE | 1 |
| t2dm cvd | DISEASE | 1 |
| t2dm atherosclerotic cvd coronary artery disease myocardial infarction | DISEASE | 1 |
| tag | ORG | 1 |
| tag glucose | CHEMICAL | 1 |
| tfrc | ORG | 1 |
| tlr9 | GPE | 1 |
| tmprss2 | CHEMICAL | 1 |
| tonic | ORG | 1 |
| table 1 | LOC | 1 |
| tan | PERSON | 1 |
| targeting parents | ORG | 1 |
| statin | CHEMICAL | 1 |
| states | GPE | 1 |
| the american academy of pediatrics | ORG | 1 |
| septic | DISEASE | 1 |
| sources studies | ORG | 1 |
| sp | CHEMICAL | 1 |
| stata | ORG | 1 |
| summary | ORG | 1 |
| sadaf farpour lambert | ORG | 1 |
| salvatore de marco | PERSON | 1 |
| sandeep aggarwal | ORG | 1 |
| sandrine | CHEMICAL | 1 |
| sang dawen | PERSON | 1 |
| schmidt et al | PERSON | 1 |
| school | ORG | 1 |
| schoolchildren ages | PERSON | 1 |
| sedentary behaviors | DISEASE | 1 |
| selective | ORG | 1 |
| septic shock | DISEASE | 1 |
| stapleton | PERSON | 1 |
| sexual dimorphism | DISEASE | 1 |
| shailendra | CHEMICAL | 1 |
| shanmugam harshitha | PERSON | 1 |
| sheridan | ORG | 1 |
| similarly busetto et al | PERSON | 1 |
| simonet | PERSON | 1 |
| simonnet | PERSON | 1 |
| singapore baseline characteristics | ORG | 1 |
| sjögren s syndrome | DISEASE | 1 |
| smoking | CHEMICAL | 1 |
| snapshot unconventional | ORG | 1 |
| societal | ORG | 1 |
| southampton | ORG | 1 |
| staiano | PERSON | 1 |
| technical | ORG | 1 |
| the biogenesis functions and challenges of circular | ORG | 1 |
| pa and sleep behaviors grip | DISEASE | 1 |
| united states details | ORG | 1 |
| type 2 diabetes mellitus | DISEASE | 1 |
| type 2 diabetic | DISEASE | 1 |
| u | ORG | 1 |
| u 3 non alcoholic fatty liver disease | CHEMICAL | 1 |
| u s public | CHEMICAL | 1 |
| uk biobank | ORG | 1 |
| uk biobank obesity in patients | ORG | 1 |
| uk national health service | ORG | 1 |
| us preventative services task force uspstf | ORG | 1 |
| usa brazil | ORG | 1 |
| ultrasonography | GPE | 1 |
| undergoing | CHEMICAL | 1 |
| unique | PERSON | 1 |
| united states department of agriculture center for nutrition policy and promotion a | ORG | 1 |
| united states factors | GPE | 1 |
| twig | PERSON | 1 |
| united states review | ORG | 1 |
| university of chicago medicine | ORG | 1 |
| urban | ORG | 1 |
| uric acid | CHEMICAL | 1 |
| user guide | PERSON | 1 |
| v title covid | CHEMICAL | 1 |
| va association | ORG | 1 |
| vas | ORG | 1 |
| vc | CHEMICAL | 1 |
| vd va | ORG | 1 |
| vo2max kg | PERSON | 1 |
| valsartan | CHEMICAL | 1 |
| varga et al | PERSON | 1 |
| interaction of sars cov | ORG | 1 |
| type 2 | DISEASE | 1 |
| trust for america s health state of childhood obesity household food security | ORG | 1 |
| the centers for disease control | ORG | 1 |
| ther clin risk manag | ORG | 1 |
| the diagnosis and management of nonalcoholic fatty liver disease practice guidance | ORG | 1 |
| the dutch eating behavior questionnaire debq | ORG | 1 |
| the effect of bariatric surgery on mobility health related quality of life healthcare resource utilization and employment status wordsworth s | ORG | 1 |
| the effectiveness of weight management programs in children and adolescents 3 | ORG | 1 |
| the euroqol group | ORG | 1 |
| the impact of childhood and adolescent obesity on cardiovascular risk | ORG | 1 |
| the johns hopkins evidence based practice center | ORG | 1 |
| the kingdom of saudi arabia | GPE | 1 |
| the mayo clinic | ORG | 1 |
| the nutrinet sante study obesity | ORG | 1 |
| the school breakfast program | ORG | 1 |
| the strong heart study screening for obstructive sleep apnea | ORG | 1 |
| the supplementary material | ORG | 1 |
| the us dietary guidelines | ORG | 1 |
| thorkild | CHEMICAL | 1 |
| trials call for prospective meta | ORG | 1 |
| thousand oaks | GPE | 1 |
| threaten | CHEMICAL | 1 |
| thrombotic complications | DISEASE | 1 |
| thrombotic microangiopathy | PERSON | 1 |
| tigran | CHEMICAL | 1 |
| time | ORG | 1 |
| timur ekiz | PERSON | 1 |
| tissue myeloid | PERSON | 1 |
| trachea statistical analysis | ORG | 1 |
| transcription | ORG | 1 |
| translating research into action for diabetes triad risk | ORG | 1 |
| translationlab | ORG | 1 |
| transmission | ORG | 1 |
| trinetx cambridge ma usa | ORG | 1 |
| sos | PERSON | 1 |
| socs | ORG | 1 |
| snp | CHEMICAL | 1 |
| practical | GPE | 1 |
| philadelphia | GPE | 1 |
| philip van gaal | PERSON | 1 |
| pho mai t | PERSON | 1 |
| physical activity | PERSON | 1 |
| physiologic | ORG | 1 |
| pickwick | ORG | 1 |
| pickwick syndrome obstructive apnea | DISEASE | 1 |
| pig | TAXON | 1 |
| plasma | PERSON | 1 |
| platelet | LOC | 1 |
| polygenic prediction of weight and obesity trajectories | ORG | 1 |
| poor health in working families | ORG | 1 |
| potential diagnostic and prognostic biomarker for diabetes mellitus | ORG | 1 |
| poyiadji et al | PERSON | 1 |
| pre lerman l o | ORG | 1 |
| peter el | PERSON | 1 |
| prediabetes | GPE | 1 |
| prediction | ORG | 1 |
| pregnancy complications | DISEASE | 1 |
| preoperative | ORG | 1 |
| preoperative prediction | PERSON | 1 |
| prevalence of obesity | ORG | 1 |
| prevalence of obesity and severe obesity | PERSON | 1 |
| prior | ORG | 1 |
| program for parents and children | ORG | 1 |
| project eating and activity | ORG | 1 |
| promotes myocardial infarction | ORG | 1 |
| proper management of people with obesity | ORG | 1 |
| prostaglandin | PERSON | 1 |
| prostaglandin e2 | CHEMICAL | 1 |
| phentermine | CHEMICAL | 1 |
| peru urgent | ORG | 1 |
| snap ed | PERSON | 1 |
| pandemic obesity | DISEASE | 1 |
| peco | ORG | 1 |
| peep | ORG | 1 |
| perudiab | ORG | 1 |
| pls | ORG | 1 |
| prs | DISEASE | 1 |
| psm n 9769 | CHEMICAL | 1 |
| pvod | DISEASE | 1 |
| pzz | ORG | 1 |
| pain | DISEASE | 1 |
| palmeira | CHEMICAL | 1 |
| palmeira antonio l roche | PERSON | 1 |
| palmitate | CHEMICAL | 1 |
| palmitate activates ccl4 expression in human monocytic cells | ORG | 1 |
| pancreatic damage | DISEASE | 1 |
| pandemics | ORG | 1 |
| peru consensus | ORG | 1 |
| parekh niyati | PERSON | 1 |
| parkinson s disease | DISEASE | 1 |
| patel | PERSON | 1 |
| pathogenic | ORG | 1 |
| pathological | PERSON | 1 |
| pathophysiology | ORG | 1 |
| patients world health organization | ORG | 1 |
| pearson chi square | LOC | 1 |
| pediatric metabolic | ORG | 1 |
| pediatric sepsis | PERSON | 1 |
| pereira santos m obesity | PERSON | 1 |
| peres riera martimbianco ward | PERSON | 1 |
| perfect storm coronavirus covid | DISEASE | 1 |
| perspective | ORG | 1 |
| psychological stress | ORG | 1 |
| psychological distress | DISEASE | 1 |
| psychosocial | ORG | 1 |
| sars epidemiological | ORG | 1 |
| rose et al | PERSON | 1 |
| roux carel w mechanick jeffrey | PERSON | 1 |
| rouxen y | ORG | 1 |
| rouxen y gastric | CHEMICAL | 1 |
| rxnorm | ORG | 1 |
| sars cov 2 covid 19 | ORG | 1 |
| sars cov 2 fig 2 | ORG | 1 |
| sars cov 2 obesity | ORG | 1 |
| sars cov 2 obesity exercise against | ORG | 1 |
| sars cov 2 pandemic infection | ORG | 1 |
| sars cov 2 rna | ORG | 1 |
| sars cov 2 infection | DISEASE | 1 |
| sars cov cov 2 | ORG | 1 |
| sars cov infections | DISEASE | 1 |
| sars h1n1 coronavirus covid | DISEASE | 1 |
| pubmed medline | GPE | 1 |
| sars mers | DISEASE | 1 |
| sars coronavirus | DISEASE | 1 |
| sars coronavirus covid | DISEASE | 1 |
| sars coronavirus sars cov 2 cell entry | DISEASE | 1 |
| sars coronavirus adaptation | DISEASE | 1 |
| sars coronavirus infection | DISEASE | 1 |
| sarscov | TAXON | 1 |
| sb a | CHEMICAL | 1 |
| sbp | ORG | 1 |
| sequel | ORG | 1 |
| slim | PERSON | 1 |
| slimm | ORG | 1 |
| slimm t2d | CHEMICAL | 1 |
| snap data tables loss of snap | ORG | 1 |
| robert h hopkins | PERSON | 1 |
| robbins | PERSON | 1 |
| ricardo v mingrone geltrude | PERSON | 1 |
| reviews | PERSON | 1 |
| pulmonary embolism | DISEASE | 1 |
| pulmonary infections | DISEASE | 1 |
| pulmonary vascular endothelialitis thrombosis | DISEASE | 1 |
| qrisk | ORG | 1 |
| qt | GPE | 1 |
| qingxian cai | PERSON | 1 |
| quality us obesity associated liver disease easl | ORG | 1 |
| quantikine elisa | PERSON | 1 |
| rna natural rna | ORG | 1 |
| ros hif | ORG | 1 |
| rt pcr | ORG | 1 |
| rapid | ORG | 1 |
| ravussin 41 | PERSON | 1 |
| rayyan | PERSON | 1 |
| referential | PERSON | 1 |
| related cardiovascular complications silencing of circular | ORG | 1 |
| renin angiotensin | PERSON | 1 |
| renin angiotensin aldosterone system blockers | PERSON | 1 |
| reproductive | ORG | 1 |
| research consortium presenting characteristics comorbidities | ORG | 1 |
| respiratory failure | DISEASE | 1 |
| respiratory syndrome | DISEASE | 1 |
| respiratory syndrome coronavirus | DISEASE | 1 |
| respiratory syndrome coronavirus 2 sars | DISEASE | 1 |
| resting ee | ORG | 1 |
| results | PERSON | 1 |
| retinal vascular dysfunction | DISEASE | 1 |
| retrospective observational study epidemiologic features and clinical course of patients infected with | ORG | 1 |
| review clinical | ORG | 1 |
| international concern | ORG | 1 |
| covid 19 coronavirus | ORG | 1 |
| intensive care units | ORG | 1 |
| covid net | DISEASE | 1 |
| covid 19 obesity | ORG | 1 |
| covid 19 obesity published | ORG | 1 |
| covid 19 obesity silver spring clinical | ORG | 1 |
| covid 19 obesity silver spring risk | ORG | 1 |
| covid 19 overweight | ORG | 1 |
| covid 19 pathological | ORG | 1 |
| covid 19 progression | ORG | 1 |
| covid 19 sars cov | ORG | 1 |
| covid 19 sars cov 2 | ORG | 1 |
| covid 19 sensitivity analysis | ORG | 1 |
| covid 19 severity | ORG | 1 |
| covid 19 studies | ORG | 1 |
| covid 19 variation | ORG | 1 |
| covid 19 date 2020 06 24 | ORG | 1 |
| covidview | ORG | 1 |
| covid 19 letter | ORG | 1 |
| cpt ventilator | ORG | 1 |
| crf habitual pa sb | ORG | 1 |
| ct genomic | ORG | 1 |
| ct manifestations of two cases | ORG | 1 |
| cvd intervention | ORG | 1 |
| cvd mcgill | ORG | 1 |
| cvd disease | DISEASE | 1 |
| cvds | DISEASE | 1 |
| cxc | ORG | 1 |
| ca | CHEMICAL | 1 |
| cai et al | PERSON | 1 |
| calif plasma | GPE | 1 |
| campinas | DISEASE | 1 |
| camporota l | PERSON | 1 |
| covid 19 mortality individuals | ORG | 1 |
| covid 19 lack | ORG | 1 |
| cardiovascular complications | DISEASE | 1 |
| codatwins | DISEASE | 1 |
| bone | ORG | 1 |
| breakfast | PERSON | 1 |
| brunault | CHEMICAL | 1 |
| cacfp | ORG | 1 |
| cardia | ORG | 1 |
| cd16 | CHEMICAL | 1 |
| cd4ϩ | CHEMICAL | 1 |
| cdr | ORG | 1 |
| cdr42020182189 | CHEMICAL | 1 |
| ce | DISEASE | 1 |
| ci 1 19 | ORG | 1 |
| city | DISEASE | 1 |
| co vid | ORG | 1 |
| codam | ORG | 1 |
| copd osa | DISEASE | 1 |
| covid 19 immunological challenges and opportunities | ORG | 1 |
| cor | ORG | 1 |
| cov obesity | ORG | 1 |
| covid 19 15 | ORG | 1 |
| covid 19 24 | ORG | 1 |
| covid 19 25 | ORG | 1 |
| covid 19 37 | ORG | 1 |
| covid 19 70 | ORG | 1 |
| covid 19 77 | ORG | 1 |
| covid 19 84 | ORG | 1 |
| covid 19 98 | ORG | 1 |
| covid 19 baseline | ORG | 1 |
| vasc health risk manag an overview and update on obesity | ORG | 1 |
| covid 19 finally | ORG | 1 |
| covid 19 hospital admission high prevalence of obesity in | ORG | 1 |
| cardiovasc med | PERSON | 1 |
| cardiovascular disease | DISEASE | 1 |
| body habitus | PERSON | 1 |
| contrary | PERSON | 1 |
| clin med doi | PERSON | 1 |
| clinical characteristics | ORG | 1 |
| clinicaltrials | ORG | 1 |
| colaus | ORG | 1 |
| cochrane handbook | PERSON | 1 |
| cochrane risk | PERSON | 1 |
| cognitive | ORG | 1 |
| colonization | DISEASE | 1 |
| comorbid | DISEASE | 1 |
| comorbidities | ORG | 1 |
| comparing | PERSON | 1 |
| concerns | GPE | 1 |
| consecutive | ORG | 1 |
| consensus | ORG | 1 |
| contrasting | GPE | 1 |
| claire sophie jannot anne | PERSON | 1 |
| cook | PERSON | 1 |
| cooperative antimicrobial therapy of septic shock catss database research group clinical | ORG | 1 |
| coronary artery disease | DISEASE | 1 |
| coronavirus 2019 ncov infection | DISEASE | 1 |
| coronavirus 2019 ncov pneumonia | DISEASE | 1 |
| coronavirus covid | DISEASE | 1 |
| coronavirus infected pneumonia | DISEASE | 1 |
| coronavirus sars cov | DISEASE | 1 |
| coronavirus disease covid | DISEASE | 1 |
| coronavirus infections | DISEASE | 1 |
| correlates of overweight and obesity among | ORG | 1 |
| correlation | ORG | 1 |
| covariates | ORG | 1 |
| covid | PERSON | 1 |
| clin med | PERSON | 1 |
| claire guerot | PERSON | 1 |
| cardiovascular diseases morbid obesity | DISEASE | 1 |
| chen | PERSON | 1 |
| cardiovascular morbidity diabetes | DISEASE | 1 |
| carlos alberto | PERSON | 1 |
| carotid intima | PERSON | 1 |
| caseload | CHEMICAL | 1 |
| cells of the olfactory epithelium identification of cell types | ORG | 1 |
| cemal | TAXON | 1 |
| centers for disease control and prevention cdc | ORG | 1 |
| central | ORG | 1 |
| centres for disease control and | ORG | 1 |
| challenges | ORG | 1 |
| chamseddine | CHEMICAL | 1 |
| chang hee koo | PERSON | 1 |
| characteristics of and important | ORG | 1 |
| chavolla | CHEMICAL | 1 |
| chester | GPE | 1 |
| cisanello hospital | ORG | 1 |
| chicago | GPE | 1 |
| child health advisory | ORG | 1 |
| childhood expert committee recommendations regarding the prevention assessment and treatment of child and adolescent overweight and | ORG | 1 |
| chile manitoba | ORG | 1 |
| china clinical | ORG | 1 |
| china epidemiological | ORG | 1 |
| china epidemiology | ORG | 1 |
| china europe | LOC | 1 |
| chronic infections | DISEASE | 1 |
| church | ORG | 1 |
| circ znf609 | PERSON | 1 |
| circpabpn1 circular | PERSON | 1 |
| circular rna | ORG | 1 |
| circular rna samd4a | PERSON | 1 |
| boirie yves bouwman | PERSON | 1 |
| bloom et al | PERSON | 1 |
| intensive care unit | ORG | 1 |
| adipose tissue inflammation | ORG | 1 |
| ards obesity | DISEASE | 1 |
| ards obesity | DISEASE | 1 |
| ats | ORG | 1 |
| audit | ORG | 1 |
| abbreviations bmi | ORG | 1 |
| abt associates | ORG | 1 |
| accelerate coronavirus vaccine licensure ethics | ORG | 1 |
| accumulating data | ORG | 1 |
| activity cards tm | PERSON | 1 |
| acute | ORG | 1 |
| adaptive | ORG | 1 |
| adenovirus | TAXON | 1 |
| adipose tissue a focus on circular rnas involved in fat deposition animals | ORG | 1 |
| adipose tissue critical players in immunometabolism obesity expands a distinct population of t cells | ORG | 1 |
| adipose tissue and increases vulnerability to infection t cell exhaustion | ORG | 1 |
| ampk | ORG | 1 |
| adolesc | CHEMICAL | 1 |
| adult care food program school | ORG | 1 |
| adults an evidence review | ORG | 1 |
| advers | CHEMICAL | 1 |
| aggression | DISEASE | 1 |
| agnieszka krela kaźmierczak iwona | PERSON | 1 |
| agnieszka ratajczak | PERSON | 1 |
| ahmet cemal pazarlı | PERSON | 1 |
| aikaterini raptis athanasios | DISEASE | 1 |
| airway | GPE | 1 |
| akhtar | GPE | 1 |
| akirov amit | PERSON | 1 |
| alcoholic steatohepatitis | DISEASE | 1 |
| alexander lambadiari | DISEASE | 1 |
| aoup patient | ORG | 1 |
| ali | ORG | 1 |
| algorithms | PERSON | 1 |
| 7722f24673acf1ca0760b34c9510458da655dff2 | DISEASE | 1 |
| 101 research | ORG | 1 |
| 104 | ORG | 1 |
| 104 induction of cathelicidins and defensins | ORG | 1 |
| 1β | CHEMICAL | 1 |
| 23014 | DISEASE | 1 |
| 267505 | DISEASE | 1 |
| 290551 | DISEASE | 1 |
| 2db28d2cd54bf5a567c433e55b4b7071707707d1 doc_id | ORG | 1 |
| 2f6878617d8b91035a1cf113d1058b73cf6591f7 | CHEMICAL | 1 |
| 3 062 covid | CHEMICAL | 1 |
| 34066 | DISEASE | 1 |
| 34a | CHEMICAL | 1 |
| 4 trust | ORG | 1 |
| 700000 | CHEMICAL | 1 |
| 8587 | DISEASE | 1 |
| ahrq | ORG | 1 |
| a ued fábio da v title | PERSON | 1 |
| abo | ORG | 1 |
| ace | ORG | 1 |
| ace 113 | CHEMICAL | 1 |
| ace 2 further aggravating this process 61 in | CHEMICAL | 1 |
| ace 2 in | CHEMICAL | 1 |
| ace 2 increasing | CHEMICAL | 1 |
| ace 2 receptor | CHEMICAL | 1 |
| ace 2 receptors | CHEMICAL | 1 |
| ace angiotensin | CHEMICAL | 1 |
| ad diarem | DISEASE | 1 |
| advance collaborative group | ORG | 1 |
| afc | ORG | 1 |
| ag | CHEMICAL | 1 |
| alexander lambadiari vaia | PERSON | 1 |
| alisa huebner | PERSON | 1 |
| blood | ORG | 1 |
| bmm apan | ORG | 1 |
| aziz khan naim | PERSON | 1 |
| b j rolls | ORG | 1 |
| bmi 2 to 20 yr | ORG | 1 |
| bmi 30 n 5879 | ORG | 1 |
| bmi 39 | ORG | 1 |
| bmi beyond bmi | ORG | 1 |
| bmi excess | ORG | 1 |
| bmi executive committee | ORG | 1 |
| bmi mortality | ORG | 1 |
| bmi office of the united states department of health and human services active | ORG | 1 |
| bmi patients | ORG | 1 |
| bmi using | ORG | 1 |
| bmi z | ORG | 1 |
| bmi Ͼ | ORG | 1 |
| bacterial | GPE | 1 |
| axis | DISEASE | 1 |
| bacteriodetes | ORG | 1 |
| bacteroidetes 93 colonization | ORG | 1 |
| baker | PERSON | 1 |
| baker jennifer lyn busetto luca | PERSON | 1 |
| balampanis konstantinos | PERSON | 1 |
| bao yi xue ban association | ORG | 1 |
| basic background information minimal | ORG | 1 |
| bello chavolla | PERSON | 1 |
| beneficial functions | ORG | 1 |
| benjamin h | PERSON | 1 |
| beverage | PERSON | 1 |
| bias | PERSON | 1 |
| biomarker for measuring lung involvement | ORG | 1 |
| biomarkers | ORG | 1 |
| azienda ospedaliero universitaria pisana aoup pisa italy | ORG | 1 |
| avivit | CHEMICAL | 1 |
| alliance | ORG | 1 |
| appendix d quality assessment forms epidemiology | ORG | 1 |
| alterations | ORG | 1 |
| am j physiol | ORG | 1 |
| ameliorates | DISEASE | 1 |
| america | GPE | 1 |
| america covid | DISEASE | 1 |
| american college of cardiology obesity the | ORG | 1 |
| american indians | ORG | 1 |
| ang 1 7 66 | ORG | 1 |
| angiotensin ii | CHEMICAL | 1 |
| animals | TAXON | 1 |
| anna maria zawada | PERSON | 1 |
| anno 1 | PERSON | 1 |
| apolipoprotein | PERSON | 1 |
| apolipoprotein e | DISEASE | 1 |
| appetitive | ORG | 1 |
| available | PERSON | 1 |
| appropriate physical activity intervention strategies for weight loss and prevention of weight regain | ORG | 1 |
| arabia | TAXON | 1 |
| archna singh | PERSON | 1 |
| argenziano | ORG | 1 |
| arkansas | GPE | 1 |
| arthrobacter luteus | PERSON | 1 |
| artificial opening endoscopic | ORG | 1 |
| assistance publique | ORG | 1 |
| association of initial viral load in severe acute respiratory syndrome | ORG | 1 |
| associations nonalcoholic steatohepatitis | ORG | 1 |
| asthma ischemic heart diseases heart failure pulmonary heart diseases cerebrovascular diseases chronic kidney disease fatty liver cirrhosis | DISEASE | 1 |
| atherogenesis | CHEMICAL | 1 |
| authorship a d and n p wrote this | CHEMICAL | 1 |
| autonomic brain centers and pathophysiology of covid | ORG | 1 |
| covid 19 infection | DISEASE | 1 |
| covid medical unit | ORG | 1 |
| covid pcr outcome | PERSON | 1 |
| hepatitis c | DISEASE | 1 |
| harshitha | DISEASE | 1 |
| hasani shamsi | PERSON | 1 |
| hassapidou maria holm | PERSON | 1 |
| hassink sandra g fairbrother gerry | ORG | 1 |
| health | ORG | 1 |
| health a focus | PERSON | 1 |
| health benefits | ORG | 1 |
| health and human services | ORG | 1 |
| healthcare research | ORG | 1 |
| healthy fitness zone | ORG | 1 |
| healthy life | PERSON | 1 |
| heart failure | DISEASE | 1 |
| heathy | DISEASE | 1 |
| hemoglobin a1c hplc | PERSON | 1 |
| herein | PERSON | 1 |
| handjieva darlenska | PERSON | 1 |
| heterogeniety | ORG | 1 |
| honk kong | GPE | 1 |
| hospital | ORG | 1 |
| hospitalization rates and characteristics of patients hospitalized with laboratory | ORG | 1 |
| host directed therapies t cells | ORG | 1 |
| household food insecurity | ORG | 1 |
| hur | ORG | 1 |
| huaping | DISEASE | 1 |
| hubei china | LOC | 1 |
| huizinga gabrielle | PERSON | 1 |
| human challenge studies | ORG | 1 |
| human infection | DISEASE | 1 |
| human monocytic cells | TAXON | 1 |
| human papillomavirus | TAXON | 1 |
| hans jacobi david | PERSON | 1 |
| hplc ms fasting | ORG | 1 |
| human monocytes | TAXON | 1 |
| gut microbes | PERSON | 1 |
| geneva world health organization | ORG | 1 |
| geneva world health organization covid | ORG | 1 |
| genome | PERSON | 1 |
| genomewide association study of severe covid 19 | ORG | 1 |
| global health services data obesity | ORG | 1 |
| global surveillance | ORG | 1 |
| golan | GPE | 1 |
| goossens gijs h dicker | ORG | 1 |
| grailer | PERSON | 1 |
| gralinski | PERSON | 1 |
| gramnegative pneumonia mice | ORG | 1 |
| greater paris | GPE | 1 |
| guan xinying chen | PERSON | 1 |
| gursimran | CHEMICAL | 1 |
| gut microbiota | PERSON | 1 |
| hip | CHEMICAL | 1 |
| h19 | ORG | 1 |
| h1h1 | GPE | 1 |
| h1n1 influenza | PERSON | 1 |
| h1n1 influenza infection | DISEASE | 1 |
| h1n1 pandemic obesity | DISEASE | 1 |
| h1n1 virus infection | DISEASE | 1 |
| h1n1pdm infection | DISEASE | 1 |
| hcc | ORG | 1 |
| hcl | CHEMICAL | 1 |
| hcov infection | DISEASE | 1 |
| hfd mice dynamic | ORG | 1 |
| hif | ORG | 1 |
| hif 1alpha glycolysis | CHEMICAL | 1 |
| hif1an | CHEMICAL | 1 |
| human cytomegalovirus | TAXON | 1 |
| humans | TAXON | 1 |
| critical care clinical characteristics of covid 19 | ORG | 1 |
| infection t | DISEASE | 1 |
| immunometabolism and pulmonary infections implications for protective immune responses | ORG | 1 |
| immunopathogenesis | GPE | 1 |
| impact of obesity on intensive care unit resource utilization after cardiac operations prevalence | ORG | 1 |
| implications | ORG | 1 |
| improvement of insulin sensitivity after lean donor feces | ORG | 1 |
| inadequacy of bmi | ORG | 1 |
| inadequate | ORG | 1 |
| inc chicago | PERSON | 1 |
| incidence of thrombotic complications | ORG | 1 |
| independent of pa | ORG | 1 |
| indirect | ORG | 1 |
| infancy | PERSON | 1 |
| infection a systematic review | ORG | 1 |
| infection morbid obesity | DISEASE | 1 |
| infections | DISEASE | 1 |
| immunologic | ORG | 1 |
| inflamed | ORG | 1 |
| inflammasome | TAXON | 1 |
| inflammasome signaling preinfection | ORG | 1 |
| inflammation c | ORG | 1 |
| influenza virus coronaviridae study group | ORG | 1 |
| influenza virus obesity | DISEASE | 1 |
| influenza virus obesity a risk factor for severe covid 19 | ORG | 1 |
| infrastructural ncrnas | ORG | 1 |
| initiation | ORG | 1 |
| innate | ORG | 1 |
| innate immunity and sepsis survival | ORG | 1 |
| insight | ORG | 1 |
| intensive care | ORG | 1 |
| intensive care national audit research centre | ORG | 1 |
| immunological basis for recurrent fetal loss | ORG | 1 |
| immune | LOC | 1 |
| hussain | GPE | 1 |
| ii bmi | ORG | 1 |
| hussain abdulzahra | PERSON | 1 |
| hydroxychloroquine chloroquine | CHEMICAL | 1 |
| hydroxymethylglutaryl | CHEMICAL | 1 |
| hyperant tm | PERSON | 1 |
| hyperleptinemia | DISEASE | 1 |
| hyperlipidemic | ORG | 1 |
| hyperplastic | LOC | 1 |
| hyposmia | GPE | 1 |
| hypothesis | ORG | 1 |
| ibm | ORG | 1 |
| ich | DISEASE | 1 |
| id | DISEASE | 1 |
| ifn deficiency | DISEASE | 1 |
| igt | ORG | 1 |
| il 1 107 | ORG | 1 |
| ill | PERSON | 1 |
| il 1 il | ORG | 1 |
| il 10 | ORG | 1 |
| il 12 | ORG | 1 |
| il 4 | ORG | 1 |
| il 6 c reactive protein | ORG | 1 |
| il 6 and 10 62 | ORG | 1 |
| il united states | GPE | 1 |
| inf lambda | PERSON | 1 |
| irb | ORG | 1 |
| iufd | ORG | 1 |
| identification of hur | ORG | 1 |
| identifier nct04288713 | ORG | 1 |
| identifying | PERSON | 1 |
| idiopathic steatohepatitis | DISEASE | 1 |
| gema mullerova | CHEMICAL | 1 |
| gema baker | CHEMICAL | 1 |
| gattinoni | PERSON | 1 |
| dobrowolska | PERSON | 1 |
| diabetes community | DISEASE | 1 |
| diabetes metab res rev doi | DISEASE | 1 |
| diabetes mellitus | DISEASE | 1 |
| diabetic ketoacidosis | DISEASE | 1 |
| diagnostic | GPE | 1 |
| diego moriconi | PERSON | 1 |
| dietary interventions | PERSON | 1 |
| dietary behaviors | DISEASE | 1 |
| dietary intake | PERSON | 1 |
| differential impact of weight loss and glycemic control | ORG | 1 |
| differentiation circular | PERSON | 1 |
| digestive and kidney diseases | DISEASE | 1 |
| disagreements | DISEASE | 1 |
| diseases injuries | DISEASE | 1 |
| dynamically expressed loss | PERSON | 1 |
| detroit | GPE | 1 |
| e6687 e6697 | PERSON | 1 |
| e78 | ORG | 1 |
| ecpo | DISEASE | 1 |
| eds | ORG | 1 |
| eds covid | ORG | 1 |
| el hasani shamsi | CHEMICAL | 1 |
| emas | ORG | 1 |
| embase | ORG | 1 |
| emc | ORG | 1 |
| erv | ORG | 1 |
| espen | ORG | 1 |
| early child care and education a key component of obesity prevention | ORG | 1 |
| early data from obesity | ORG | 1 |
| eculizumab | CHEMICAL | 1 |
| di figlia | CHEMICAL | 1 |
| detection of sars | ORG | 1 |
| gastric bypass roux | PERSON | 1 |
| d structure | ORG | 1 |
| critical care medicine clinical | ORG | 1 |
| critical roles | ORG | 1 |
| cross | ORG | 1 |
| cross sectional prevalence study quality | ORG | 1 |
| cross sectional prevalence study quality agency for healthcare research | ORG | 1 |
| crowl | GPE | 1 |
| cueto | CHEMICAL | 1 |
| cueto et | PERSON | 1 |
| cytokine chemokine | LOC | 1 |
| cytokine receptors blockade | ORG | 1 |
| czernichow sébastien beeker | PERSON | 1 |
| d caironi | PERSON | 1 |
| d langin k | CHEMICAL | 1 |
| d langin k campbell | ORG | 1 |
| dbt icmr | ORG | 1 |
| designated hospital | ORG | 1 |
| dbt wellcome trust india alliance | ORG | 1 |
| dec | ORG | 1 |
| dm obesity | DISEASE | 1 |
| dxa body | ORG | 1 |
| dxa expanded | PERSON | 1 |
| dana woodward euan holm jens christian | PERSON | 1 |
| danone research | ORG | 1 |
| david | PERSON | 1 |
| david mcgowan barbara m pan | PERSON | 1 |
| death | DISEASE | 1 |
| deaths | DISEASE | 1 |
| deeper | PERSON | 1 |
| deierlein andrea l | PERSON | 1 |
| depression | DISEASE | 1 |
| efeitos da suplementação | PERSON | 1 |
| effectiveness of | ORG | 1 |
| eicosapentaenoic epa | CHEMICAL | 1 |
| france gautier | ORG | 1 |
| fang | PERSON | 1 |
| fang ming fang zhao yun shao huaping | PERSON | 1 |
| farpour lambert | PERSON | 1 |
| fat addiction psychological and physiological trajectory taste | ORG | 1 |
| fat sensation fatty acid taste and olfaction sensitivity | ORG | 1 |
| fatty | ORG | 1 |
| fatty acid | CHEMICAL | 1 |
| fatty acids | CHEMICAL | 1 |
| felicia chiarito mariangela molina molina | CHEMICAL | 1 |
| fetal loss | DISEASE | 1 |
| fitnessgram | ORG | 1 |
| florida | GPE | 1 |
| framingham | ORG | 1 |
| framingham risk scores homeostasis | ORG | 1 |
| france impact of obesity | ORG | 1 |
| electronic media branch division of news and electronic media office of the associate director of communication | ORG | 1 |
| francesco cohen | PERSON | 1 |
| francisca | CHEMICAL | 1 |
| frank | CHEMICAL | 1 |
| frank krawczyk marcin d amato gabriele portincasa piero | PERSON | 1 |
| freedman | PERSON | 1 |
| ga saa | CHEMICAL | 1 |
| gerd | DISEASE | 1 |
| gi | ORG | 1 |
| gpr120 mediated | ORG | 1 |
| gravitas | ORG | 1 |
| ga | CHEMICAL | 1 |
| gallstone | DISEASE | 1 |
| gao t hu m zhang x li h zhu l liu h dong q zhang | PERSON | 1 |
| gastric bypass | PERSON | 1 |
| family | ORG | 1 |
| familial | ORG | 1 |
| faienza | CHEMICAL | 1 |
| ORG | 1 | |
| eleni | CHEMICAL | 1 |
| elevated bmi | ORG | 1 |
| elmaogullari | ORG | 1 |
| emmanuel diehl | PERSON | 1 |
| endocrinol lausanne | PERSON | 1 |
| endotoxin | CHEMICAL | 1 |
| endotoxins | PERSON | 1 |
| energy metabolism after continuous positive airway pressure for obstructive sleep apnea effect of continuous positive airway pressure on glycemic control in patients with obstructive sleep apnea | ORG | 1 |
| epicentro | PERSON | 1 |
| epidemiology working group for ncip epidemic response chinese center for disease control and prevention | ORG | 1 |
| epworth | LOC | 1 |
| epworth sleepiness | DISEASE | 1 |
| equally | ORG | 1 |
| erica l | PERSON | 1 |
| ethicon johnson johnson l tappy | PERSON | 1 |
| eun jung | PERSON | 1 |
| europe who working group for risk factors for severe h1n1pdm infection risk | ORG | 1 |
| european association for the study of obesity covid | ORG | 1 |
| executive committee | ORG | 1 |
| expanded | ORG | 1 |
| expert | ORG | 1 |
| expert committee | ORG | 1 |
| extracellular vesicles a possible mechanism for circrna clearance | ORG | 1 |
| extraordinary diseases | DISEASE | 1 |
| fda | ORG | 1 |
| fema | ORG | 1 |
| fev | ORG | 1 |
| frc | ORG | 1 |
| fsh | ORG | 1 |
| varga et al 34 | PERSON | 1 |
| fits | DISEASE | 1 |
| venous thromboembolism | DISEASE | 1 |
| obstructive pulmonary disease | DISEASE | 1 |
| obesity cardiovascular diseases | DISEASE | 1 |
| obesity cluster | DISEASE | 1 |
| obesity disordered breathing during sleep | DISEASE | 1 |
| obesity infection | DISEASE | 1 |
| obesity metabolic syndrome | DISEASE | 1 |
| obesity myeloid | DISEASE | 1 |
| obesity sarcopenic obesity | DISEASE | 1 |
| obesity stigma | DISEASE | 1 |
| obesity stigma jokes | DISEASE | 1 |
| obesity type 2 diabetes | DISEASE | 1 |
| obesity type 2 diabetes mellitus | DISEASE | 1 |
| obesogenic behavior | DISEASE | 1 |
| obesogenic behaviors | DISEASE | 1 |
| obstructive coronary artery disease | DISEASE | 1 |
| obstructive sleep apnea a | DISEASE | 1 |
| obesity takotsubo cardiomyopathy | DISEASE | 1 |
| obstructive sleep apnea ahi | DISEASE | 1 |
| obstructive sleep apnea syndrome obesity | DISEASE | 1 |
| obstructive sleep apnea syndrome asthma restrictive respiratory syndrome | DISEASE | 1 |
| obstructive sleep apnoea | DISEASE | 1 |
| obstructive sleep apnoea diabetes | DISEASE | 1 |
| oily spotting fecal urgency | CHEMICAL | 1 |
| olfactory and gustatory dysfunction | DISEASE | 1 |
| olfactory loss | DISEASE | 1 |
| olmesartan | CHEMICAL | 1 |
| omega 3 polyunsaturated fatty acids | CHEMICAL | 1 |
| omentin | CHEMICAL | 1 |
| organ dysfunction | DISEASE | 1 |
| organ injury | DISEASE | 1 |
| organism | TAXON | 1 |
| obesity cardiovascular and liver | DISEASE | 1 |
| obesity obstructive sleep apnea syndrome | DISEASE | 1 |
| oropharyngeal or nasal swab 19 8 | DISEASE | 1 |
| nutrient malabsorption | DISEASE | 1 |
| nonalcoholic fatty liver nafl | DISEASE | 1 |
| nonalcoholic fatty liver disease metformin | DISEASE | 1 |
| nonalcoholic fatty liver disease nonalcoholic fatty liver disease nonalcoholic fatty liver disease | DISEASE | 1 |
| nonalcoholic fatty liver disease cysteamine bitartrate | DISEASE | 1 |
| nonalcoholic steatohepatitis | DISEASE | 1 |
| nonalcoholic steatohepatitis nash | DISEASE | 1 |
| noncommunicable disease | DISEASE | 1 |
| noncommunicable diseases ncds | DISEASE | 1 |
| norepinephrine | CHEMICAL | 1 |
| nosocomial infection | DISEASE | 1 |
| novel_circ_0001494 | ORG | 1 |
| novel_circ_0010775 novel_circ_0006981 | ORG | 1 |
| nucleotide | CHEMICAL | 1 |
| nutrient deficiencies | DISEASE | 1 |
| nutritional and behavioural | DISEASE | 1 |
| obesity obesity cardiomyopathy | DISEASE | 1 |
| nutritional cardiac respiratory renal | DISEASE | 1 |
| nutritional complications | DISEASE | 1 |
| obese childrenand | GPE | 1 |
| obese heart failure | DISEASE | 1 |
| obese patients association of blood glucose control | ORG | 1 |
| obese pregnancy | DISEASE | 1 |
| obese vs | GPE | 1 |
| obesity cvd | DISEASE | 1 |
| obesity cvd diabetes | DISEASE | 1 |
| obesity chloroquine | DISEASE | 1 |
| obesity cognitive behavioral | DISEASE | 1 |
| obesity lung function obesity | DISEASE | 1 |
| obesity n | DISEASE | 1 |
| obesity ncds | DISEASE | 1 |
| oropharyngeal or nasal swab | DISEASE | 1 |
| osteoarthritis chronic kidney disease | DISEASE | 1 |
| reduction in diastolic blood pressure | DISEASE | 1 |
| pulmonary disorders | DISEASE | 1 |
| prolonged lockdowns for coronavirus disease | DISEASE | 1 |
| propylthiouracil | CHEMICAL | 1 |
| prostaglandin e | CHEMICAL | 1 |
| prostate cancer | DISEASE | 1 |
| proteinuria | DISEASE | 1 |
| proterin | CHEMICAL | 1 |
| proton | PERSON | 1 |
| psychiatric | DISEASE | 1 |
| psychosocial disorders | DISEASE | 1 |
| pulmonary alveolus | DISEASE | 1 |
| pulmonary angiopathy | DISEASE | 1 |
| pulmonary complications | DISEASE | 1 |
| pulmonary disease | DISEASE | 1 |
| pulmonary diseases | DISEASE | 1 |
| pulmonary hypertension | DISEASE | 1 |
| procalcitonin | CHEMICAL | 1 |
| pulmonary infections | DISEASE | 1 |
| pulmonary injury | DISEASE | 1 |
| pulmonary insufficiency | DISEASE | 1 |
| pulmonary lipotoxicity fatty acid | DISEASE | 1 |
| pulmonary syndrome | DISEASE | 1 |
| pulmonary vascular disease | DISEASE | 1 |
| pulmonary vascular dysfunction | DISEASE | 1 |
| pulmonary vascular inflammation | DISEASE | 1 |
| pulmonary viral infections | DISEASE | 1 |
| purpura | DISEASE | 1 |
| quantify pa | ORG | 1 |
| quinapril | CHEMICAL | 1 |
| rash | DISEASE | 1 |
| rat spermatozoa | TAXON | 1 |
| prolonged disability | DISEASE | 1 |
| premature death | DISEASE | 1 |
| osteoporosis | DISEASE | 1 |
| phentermine | CHEMICAL | 1 |
| outbreaks | TAXON | 1 |
| overload | DISEASE | 1 |
| oxalate sodium phosphate | CHEMICAL | 1 |
| palmitate | CHEMICAL | 1 |
| pancreatic diseases | DISEASE | 1 |
| pancreatic injury | DISEASE | 1 |
| pandemic infection | DISEASE | 1 |
| papilloma virus incident infection | DISEASE | 1 |
| pathogen | ORG | 1 |
| pathway natural | ORG | 1 |
| pathways participation | ORG | 1 |
| perilipin | CHEMICAL | 1 |
| peripheral vascular disease | DISEASE | 1 |
| permanent damage | DISEASE | 1 |
| phentermine orlistat | CHEMICAL | 1 |
| pregnancy complications | DISEASE | 1 |
| phentermine topiramate | CHEMICAL | 1 |
| phenterminetopiramate | CHEMICAL | 1 |
| phylum | TAXON | 1 |
| pioglitazone | CHEMICAL | 1 |
| pizza hamburgers fried | CHEMICAL | 1 |
| placental trophoblast | TAXON | 1 |
| platelet aggregation | DISEASE | 1 |
| pleural and esophageal pressures | DISEASE | 1 |
| pneumonia pleiotropic | ORG | 1 |
| polyinosinic polycytidylic acid | CHEMICAL | 1 |
| polypyrimidine | CHEMICAL | 1 |
| potassium magnesium calcium | CHEMICAL | 1 |
| prandial | CHEMICAL | 1 |
| pregnancy pregnancy | DISEASE | 1 |
| nonalcoholic fatty liver | DISEASE | 1 |
| nitrites | CHEMICAL | 1 |
| nitric | CHEMICAL | 1 |
| lung lesions | DISEASE | 1 |
| lncrna | ORG | 1 |
| lncrnas | ORG | 1 |
| lopinavir ritonavir | CHEMICAL | 1 |
| loss | DISEASE | 1 |
| loss in gustatory taste perception | DISEASE | 1 |
| loss of appetite | DISEASE | 1 |
| loss of muscle mass | DISEASE | 1 |
| loss of olfactory neurons and odor perception | DISEASE | 1 |
| loss of olfactory sensory neurons and olfaction sensitivity the olfactory mucosa | DISEASE | 1 |
| loss of smell | DISEASE | 1 |
| low self esteem | DISEASE | 1 |
| lu6hj3a2 obesity | DISEASE | 1 |
| lung damage | DISEASE | 1 |
| lung injury 111 | DISEASE | 1 |
| lung microvascular dysfunction vascular leakage alveolar oedema | DISEASE | 1 |
| liver muscle | DISEASE | 1 |
| lupus erythematosus | DISEASE | 1 |
| lupus nephritis | DISEASE | 1 |
| lymphocytopenia | DISEASE | 1 |
| macrovascular | DISEASE | 1 |
| major diseases 9 | DISEASE | 1 |
| major infections | DISEASE | 1 |
| malignancies heart failure | DISEASE | 1 |
| malignant behavior | DISEASE | 1 |
| mammalian cells | TAXON | 1 |
| mass index abdominal fatness | DISEASE | 1 |
| maternal obesity | DISEASE | 1 |
| matter nonalcoholic steatohepatitis | DISEASE | 1 |
| melatonin | CHEMICAL | 1 |
| memory t | DISEASE | 1 |
| liver steatosis steatohepatitis | DISEASE | 1 |
| liver malignant neoplasm | DISEASE | 1 |
| nicotine | CHEMICAL | 1 |
| labor | DISEASE | 1 |
| intestinal microbiota dysbiosis | DISEASE | 1 |
| intracranial hypertension nash | DISEASE | 1 |
| intravascular coagulation dic | DISEASE | 1 |
| intravascular thrombosis | DISEASE | 1 |
| invulnerability | DISEASE | 1 |
| iron a | CHEMICAL | 1 |
| isac | ORG | 1 |
| ischaemic | DISEASE | 1 |
| ischemia | DISEASE | 1 |
| jcm9072158 | CHEMICAL | 1 |
| jomes20056 | CHEMICAL | 1 |
| journal public | ORG | 1 |
| kg | PERSON | 1 |
| kidney injury | DISEASE | 1 |
| labor a | DISEASE | 1 |
| liver diseases | DISEASE | 1 |
| leflunomide | CHEMICAL | 1 |
| leptin leptin | PERSON | 1 |
| leptin tumor necrosis | DISEASE | 1 |
| leukocyte | PERSON | 1 |
| leukopenia lymphopenia | DISEASE | 1 |
| lipid droplet accumulation | ORG | 1 |
| lipopolysaccharides | CHEMICAL | 1 |
| lipoprotein lipase inflammation | DISEASE | 1 |
| lipoproteins | CHEMICAL | 1 |
| lipotoxic | DISEASE | 1 |
| liver abnormalities | DISEASE | 1 |
| liver and skeletal muscle | DISEASE | 1 |
| liver cancer | DISEASE | 1 |
| liver disease nash | DISEASE | 1 |
| meta bolic operations panel | ORG | 1 |
| metabolic 212 syndrome | DISEASE | 1 |
| metabolic 270 inflexibility | DISEASE | 1 |
| naltrexone bupropion | CHEMICAL | 1 |
| multiorgan damage | DISEASE | 1 |
| multiple disease | DISEASE | 1 |
| multisystem chronic disease | DISEASE | 1 |
| multisystemic | DISEASE | 1 |
| murine macrophages | TAXON | 1 |
| muscle and airway hyperresponsiveness | DISEASE | 1 |
| muscle mass loss | DISEASE | 1 |
| muscle pancreas liver | DISEASE | 1 |
| musculoskeletal pain | DISEASE | 1 |
| myeloid | DISEASE | 1 |
| myeloid inflammation | DISEASE | 1 |
| ncov acute respiratory disease | DISEASE | 1 |
| ncov infected | DISEASE | 1 |
| naltrexone | CHEMICAL | 1 |
| nasal congestion | DISEASE | 1 |
| metabolic alterations | DISEASE | 1 |
| nasal infections | DISEASE | 1 |
| natriuretic peptides obesity metabolic syndrome | DISEASE | 1 |
| nausea tingling bowel | DISEASE | 1 |
| necrosis | DISEASE | 1 |
| necrotic | DISEASE | 1 |
| nephropathy | DISEASE | 1 |
| nephrotoxic | DISEASE | 1 |
| neurodegenerative disorders | DISEASE | 1 |
| neuroinvasive | TAXON | 1 |
| neurological complications | DISEASE | 1 |
| neuronal death | DISEASE | 1 |
| neuropathy | DISEASE | 1 |
| neuropsychiatric signs | DISEASE | 1 |
| neutrophilia | DISEASE | 1 |
| multiorgan | GPE | 1 |
| multifactorial disorder | DISEASE | 1 |
| multicentre | PERSON | 1 |
| morbidity teen | DISEASE | 1 |
| metabolic and cardiovascular and hepatic consequences data sources | DISEASE | 1 |
| metabolic and cardiovascular complications | DISEASE | 1 |
| metabolic cirrhosis | DISEASE | 1 |
| metabolic degeneration | DISEASE | 1 |
| metabolic deterioration | DISEASE | 1 |
| metabolic disturbances | DISEASE | 1 |
| metabolic dysregulation | DISEASE | 1 |
| metabolic dysregulation tumor necrosis | DISEASE | 1 |
| metabolic dysregulations | DISEASE | 1 |
| metabolic sequelae | DISEASE | 1 |
| metabolic syndrome cholesterol | DISEASE | 1 |
| metabolic trauma | DISEASE | 1 |
| mirnas circular | PERSON | 1 |
| mice palmitate | TAXON | 1 |
| mice platelet | TAXON | 1 |
| mice macrophages | TAXON | 1 |
| micrornas | PERSON | 1 |
| microbial death | DISEASE | 1 |
| micronutrient deficiencies | DISEASE | 1 |
| micronutrient insufficiency | DISEASE | 1 |
| microthrombi | DISEASE | 1 |
| microthrombosis | DISEASE | 1 |
| microvascular and macrovascular complications | DISEASE | 1 |
| microvascular injury | DISEASE | 1 |
| min | ORG | 1 |
| mineral | CHEMICAL | 1 |
| mineral deficiencies | DISEASE | 1 |
| mitochondrial dysfunction | DISEASE | 1 |
| monocytosis | DISEASE | 1 |
| reduced oro sensory perception | DISEASE | 1 |
| reduction in food insecurity | DISEASE | 1 |
| intestinal barrier dysfunction | DISEASE | 1 |
| the world health organization 1 2 interestingly the united states of america | ORG | 1 |
| the united states dairy association usda | GPE | 1 |
| the united states development of food | GPE | 1 |
| the united states diabetes prevention | GPE | 1 |
| the united states food and drug administration | ORG | 1 |
| the united states food and drug administration usfda | ORG | 1 |
| the united states preventive services task force uspstf | ORG | 1 |
| the united states u s | GPE | 1 |
| the universidade federal de são paulo unifesp | ORG | 1 |
| the university of campinas unicamp | ORG | 1 |
| the university of chicago medical center | ORG | 1 |
| the university of delaware | ORG | 1 |
| the western hemisphere prevalence | ORG | 1 |
| the white house conference on food nutrition and health | ORG | 1 |
| the world health organization 1 | ORG | 1 |
| the world health organization who | ORG | 1 |
| the united states ace2 expression | GPE | 1 |
| the world health organization who and centers for disease control | ORG | 1 |
| the associated cardio metabolic complications | ORG | 1 |
| the association of obesity | ORG | 1 |
| the expert committee on | ORG | 1 |
| the institutional review board | ORG | 1 |
| the maternal fetal interface immunology | ORG | 1 |
| the north east | LOC | 1 |
| thiamine | CHEMICAL | 1 |
| thrombocytopenic | DISEASE | 1 |
| thromboembolic | DISEASE | 1 |
| thrombotic disseminated | DISEASE | 1 |
| thrombotic microangiopathy | DISEASE | 1 |
| thrombotic thrombocytopenic purpura hemolytic uremic 523 syndrome | DISEASE | 1 |
| thromboxane | CHEMICAL | 1 |
| the united states association | GPE | 1 |
| the usa centres for disease control and prevention 21 | ORG | 1 |
| tissue damage organ failure | DISEASE | 1 |
| the republic of korea | GPE | 1 |
| the middle east | LOC | 1 |
| the ministry of health | ORG | 1 |
| the monocyte compartment in human obesity inflammatory | ORG | 1 |
| the national health commission state administration of traditional chinese medicine frequency | ORG | 1 |
| the national health commission trial version | ORG | 1 |
| the national health commission trial version 6 association | ORG | 1 |
| the national health and nutrition examination survey | ORG | 1 |
| the national household education surveys program of 2016 | ORG | 1 |
| the national institute of diabetes and digestive and kidney diseases nddk | ORG | 1 |
| the national institutes of health the adopt accumulating data | ORG | 1 |
| the new york city area | GPE | 1 |
| the new york city area clinical | LOC | 1 |
| the nutrition of preschoolers obesity | ORG | 1 |
| the paffenbarger physical activity questionnaire | ORG | 1 |
| the sars cov 2 | ORG | 1 |
| the us obesity | ORG | 1 |
| the school breakfast program sbp | ORG | 1 |
| the scientific and ethical committee | ORG | 1 |
| the seattle region case series initializing | LOC | 1 |
| the seattle region case series obesity in patients | LOC | 1 |
| the summer food service program | ORG | 1 |
| the summer food service program children in immigrant families essential to america s future | ORG | 1 |
| the teen labs | ORG | 1 |
| the three dimensions etiology degree of adiposity and health risk childhood | ORG | 1 |
| the translating research into action for diabetes triad study | ORG | 1 |
| the u s department of agriculture usda | ORG | 1 |
| the u s preventive services task force c | ORG | 1 |
| the u s preventive services task force rockville agency | ORG | 1 |
| the us department of agriculture | ORG | 1 |
| the us department of agriculture food and nutrition service | ORG | 1 |
| thyroid cancer | DISEASE | 1 |
| tissue dysfunction | DISEASE | 1 |
| reduction of lung injury | DISEASE | 1 |
| weight failure | DISEASE | 1 |
| viral invasion | DISEASE | 1 |
| viral pneumonias | DISEASE | 1 |
| viral respiratory disease | DISEASE | 1 |
| viral respiratory infections | DISEASE | 1 |
| virulent infuenza virus | TAXON | 1 |
| virus people | TAXON | 1 |
| virus obesity | DISEASE | 1 |
| vitamin 102 | CHEMICAL | 1 |
| vitamin a vitamin d iron | CHEMICAL | 1 |
| vitamin c n 3 fatty acids | CHEMICAL | 1 |
| vitamins a c d | CHEMICAL | 1 |
| vitamins a e | CHEMICAL | 1 |
| vomiting hypoxia | DISEASE | 1 |
| vomiting nausea | DISEASE | 1 |
| weight obesity | DISEASE | 1 |
| viral inclusion | TAXON | 1 |
| weight bias | DISEASE | 1 |
| weight loss obesity | DISEASE | 1 |
| weight loss behaviors | DISEASE | 1 |
| weight overweight | DISEASE | 1 |
| weight teasing | DISEASE | 1 |
| weight visual changes rash weakness oedema | DISEASE | 1 |
| workers infected | DISEASE | 1 |
| www karger | PERSON | 1 |
| x7g3jcjm | CHEMICAL | 1 |
| xanthine | CHEMICAL | 1 |
| xanthine oxidase | PERSON | 1 |
| zinc copper selenium iron | CHEMICAL | 1 |
| β catenin | PERSON | 1 |
| β catenin gene | PERSON | 1 |
| viral infections obesity | DISEASE | 1 |
| viral host cell | TAXON | 1 |
| toxicity | DISEASE | 1 |
| type ii | DISEASE | 1 |
| transferrin | CHEMICAL | 1 |
| triglycerides | CHEMICAL | 1 |
| tumour necrosis | DISEASE | 1 |
| type 1 diabetes t1d | DISEASE | 1 |
| type 2 diabetes covid | DISEASE | 1 |
| type 2 diabetes obesity | DISEASE | 1 |
| type 2 diabetes t2dm kidney disease | DISEASE | 1 |
| type 2 diabetes cardiovascular diseases | DISEASE | 1 |
| type 2 diabetes lipotoxicity glucotoxicity | DISEASE | 1 |
| type 2 diabetes mellitus diabetes | DISEASE | 1 |
| type 2 diabetes mellitus t2dm | DISEASE | 1 |
| type 2 diabetes mellitus polycystic ovary syndrome sleep apnea musculoskeletal disorders | DISEASE | 1 |
| type 2 diabetes obesity | DISEASE | 1 |
| type 2 diabetic | DISEASE | 1 |
| uk prospero display_record | ORG | 1 |
| viral envelope spike glycoprotein | TAXON | 1 |
| undernutrition obesity | DISEASE | 1 |
| undue fatigue | DISEASE | 1 |
| uric acid obesity | CHEMICAL | 1 |
| urinary lithiasis | DISEASE | 1 |
| ursodeoxycholic acid | CHEMICAL | 1 |
| uterine inflammation | DISEASE | 1 |
| vascular abnormalities | DISEASE | 1 |
| vascular inflammation | DISEASE | 1 |
| venous congestion | DISEASE | 1 |
| venous thrombosis | DISEASE | 1 |
| ventilation syndrome | DISEASE | 1 |
| viral disease | DISEASE | 1 |
| viral diseases | DISEASE | 1 |
| viral envelope | TAXON | 1 |
| the maternal and child health bureau of the health resources and services administration hrsa department of health and human services | ORG | 1 |
| the lombardy region italy characteristics | ORG | 1 |
| the lombardy region features | LOC | 1 |
| splenomegaly | DISEASE | 1 |
| skeletal muscle | DISEASE | 1 |
| skeletal muscle injury delirium | DISEASE | 1 |
| sleep obesity | DISEASE | 1 |
| sleep apnea diabetes hypertension | DISEASE | 1 |
| sleep apnea vitamin d deficiency | DISEASE | 1 |
| sleep apnoea | DISEASE | 1 |
| sleep behaviors | DISEASE | 1 |
| sleep disorder | DISEASE | 1 |
| sleep disordered breathing | DISEASE | 1 |
| sleep problems | DISEASE | 1 |
| snoring obesity | DISEASE | 1 |
| sodium chloride | CHEMICAL | 1 |
| sodium glucose | CHEMICAL | 1 |
| solitaris nts | PERSON | 1 |
| status disease | DISEASE | 1 |
| sha 43f4d80cf1b7a313c4c287287d824caac85481aa doc_id | CHEMICAL | 1 |
| steatohepatitis fibrosis | DISEASE | 1 |
| steroid | CHEMICAL | 1 |
| sterol | CHEMICAL | 1 |
| stigmatization | DISEASE | 1 |
| stigmatization language | DISEASE | 1 |
| stod75j2 | ORG | 1 |
| stress obesity | DISEASE | 1 |
| stress begets | DISEASE | 1 |
| stroke angina | DISEASE | 1 |
| subjective olfactory dysfunction | DISEASE | 1 |
| substance abuse dietary | DISEASE | 1 |
| sucrose | CHEMICAL | 1 |
| sudden loss of their senses of smell and taste | DISEASE | 1 |
| suicide | DISEASE | 1 |
| sha 46c709164dda2ed85f3b3e28a6fca2214d70944e | CHEMICAL | 1 |
| serviço | CHEMICAL | 1 |
| the local ethics committee association | ORG | 1 |
| respiratory viral infection obesity | DISEASE | 1 |
| reflux oesophagitis | DISEASE | 1 |
| renal complications | DISEASE | 1 |
| renal dysfunction | DISEASE | 1 |
| respiratory disease infections | DISEASE | 1 |
| respiratory distress syndrome mers cov infection | DISEASE | 1 |
| respiratory failure syndrome | DISEASE | 1 |
| respiratory illness | DISEASE | 1 |
| respiratory muscle | DISEASE | 1 |
| respiratory obesity hypoventilation syndrome cardiac or renal complications | DISEASE | 1 |
| respiratory syndrome coronavirus 2 sars cov | DISEASE | 1 |
| respiratory syndrome coronavirus causes multiple organ damage | DISEASE | 1 |
| respiratory system lung and chest wall mechanics | DISEASE | 1 |
| respiratory tract infections rti | DISEASE | 1 |
| respiratory viral disease | DISEASE | 1 |
| respiratory viral infections | DISEASE | 1 |
| septic shock | DISEASE | 1 |
| retinal complications | DISEASE | 1 |
| rhinorrhea | DISEASE | 1 |
| rosuvastatin | CHEMICAL | 1 |
| rupture | DISEASE | 1 |
| ruxolitinib | CHEMICAL | 1 |
| s move | PERSON | 1 |
| saturated fatty acids sfas | CHEMICAL | 1 |
| seasonal influenza virus infection thrombotic microangiopathy | DISEASE | 1 |
| secondary glomerular sclerosis | DISEASE | 1 |
| secretory iga | DISEASE | 1 |
| sedentary behavior | DISEASE | 1 |
| sedentary behaviors sleep | DISEASE | 1 |
| sepsis obesity | DISEASE | 1 |
| septic | DISEASE | 1 |
| superoxide | CHEMICAL | 1 |
| surfactant dysfunctions | DISEASE | 1 |
| syncytial virus | TAXON | 1 |
| the french data protection authority commission nationale de l informatique | ORG | 1 |
| the dutch guidelines | ORG | 1 |
| the easo european coalition for people living with obesity ecpo easo | ORG | 1 |
| the edmonton obesity staging system | ORG | 1 |
| the emergency department information | ORG | 1 |
| the emotional pa | ORG | 1 |
| the european association for the study of diabetes easd metabolic | ORG | 1 |
| the european association for the study of obesity | ORG | 1 |
| the european association for the study of obesity easo | ORG | 1 |
| the european association for the study of obesity on immunological perturbations therapeutic challenges and opportunities in obesity | ORG | 1 |
| the european commission | ORG | 1 |
| the european society of paediatric radiology cardiothoracic imaging taskforce coronavirus | ORG | 1 |
| the executive committee of easo | ORG | 1 |
| the executive committee of the easo | ORG | 1 |
| the food guide pyramid | ORG | 1 |
| the french national research agency | ORG | 1 |
| syndromic obesity | DISEASE | 1 |
| the french society of pharmacology therapeutics renin | ORG | 1 |
| the future early childhood program participation | ORG | 1 |
| the hartman group | ORG | 1 |
| the infectious diseases society of america | ORG | 1 |
| the institutional review board | ORG | 1 |
| the international association for gerontology and geriatrics iagg asia oceania region association | ORG | 1 |
| the international classification | ORG | 1 |
| the international classification of diseases | ORG | 1 |
| the international committee on taxonomy of v | ORG | 1 |
| the italian world health organization and international obesity task force references high | ORG | 1 |
| the joint programming initiative | ORG | 1 |
| the joint programming initiative a healthy diet | ORG | 1 |
| the king s obesity criteria 37 | ORG | 1 |
| the life course obesity | ORG | 1 |
| the diabetes community | ORG | 1 |
| the development of adult type 2 | ORG | 1 |
| the cytokine storm | LOC | 1 |
| the creative commons attribution license cc by | ORG | 1 |
| syrup | CHEMICAL | 1 |
| trnas | CHEMICAL | 1 |
| tachypnea | DISEASE | 1 |
| tango stress | ORG | 1 |
| taste and smell sensation | DISEASE | 1 |
| taste disorders | DISEASE | 1 |
| teenlongitudinal | DISEASE | 1 |
| testis | DISEASE | 1 |
| testosterone | CHEMICAL | 1 |
| thalidomide | CHEMICAL | 1 |
| the ap hp | ORG | 1 |
| the academy of nutrition and dietetics interventions | ORG | 1 |
| the agency for healthcare research and quality | ORG | 1 |
| the alcohol use disorders identification test audit obesity | ORG | 1 |
| the american college of sports medicine | ORG | 1 |
| the american heart association | ORG | 1 |
| the american heart association physical | ORG | 1 |
| the atherosclerosis risk in communities study internet obesity silver spring | ORG | 1 |
| the behavioral health and nutrition department | ORG | 1 |
| the berlin definition childhood | GPE | 1 |
| the canadian national population health survey screening | ORG | 1 |
| the cardiovascular health epidemiology study ches | ORG | 1 |
| the center for disease control and prevention | ORG | 1 |
| the chinese center for disease control and prevention | ORG | 1 |
| the chinese center for disease control and prevention clinical | ORG | 1 |
| the chinese center for disease control and prevention epidemiological | ORG | 1 |
| the choose myplate | LOC | 1 |
| the coronavirus study group severe | ORG | 1 |
| the creative commons attribution cc | ORG | 1 |
| intestinal inflammation | DISEASE | 1 |
| intestinal lactobacillus | DISEASE | 1 |
| venturi mask | PERSON | 1 |
| breathing disorder | DISEASE | 1 |
| azithromycin | CHEMICAL | 1 |
| bacteria | TAXON | 1 |
| bacterial infection | DISEASE | 1 |
| bacterial lipopolysaccharides | TAXON | 1 |
| bacterial phyla | TAXON | 1 |
| balloon injury | DISEASE | 1 |
| bedsores | DISEASE | 1 |
| betacoronavirus emc | CHEMICAL | 1 |
| betacoronavirus sars | CHEMICAL | 1 |
| biguanide | CHEMICAL | 1 |
| binge and emotional eating | DISEASE | 1 |
| birth and birth weight macrosomia | DISEASE | 1 |
| blood pressure cardiovascular diseases | DISEASE | 1 |
| breast cancer | DISEASE | 1 |
| bronchial smooth muscle | DISEASE | 1 |
| autoimmune pathologies | DISEASE | 1 |
| bronchitis sarcoidosis obstructive sleep apnea | DISEASE | 1 |
| bupropion | CHEMICAL | 1 |
| burn | DISEASE | 1 |
| butanol | CHEMICAL | 1 |
| c7c8eab93260ff21bfd57f098e9de51188bcb92c | CHEMICAL | 1 |
| cachexia | DISEASE | 1 |
| cancers | DISEASE | 1 |
| cancers cholelithiasis infertility | DISEASE | 1 |
| capillary microangiopathy | DISEASE | 1 |
| captopril | CHEMICAL | 1 |
| carcinogenesis | DISEASE | 1 |
| cardiac hypertrophy | DISEASE | 1 |
| cardiac injury | DISEASE | 1 |
| cardiometabolic comorbidities | DISEASE | 1 |
| autoimmunity | DISEASE | 1 |
| autoimmune and inflammatory diseases | DISEASE | 1 |
| cardiovascular abnormalities | DISEASE | 1 |
| apnea | DISEASE | 1 |
| alveolus | DISEASE | 1 |
| amino acid malnutrition | CHEMICAL | 1 |
| an expert committee | ORG | 1 |
| anasarca | DISEASE | 1 |
| angiotensin 1 7 improves | CHEMICAL | 1 |
| angiotensin 1 7 in | CHEMICAL | 1 |
| angiotensin i | CHEMICAL | 1 |
| angiotensin peptide | CHEMICAL | 1 |
| animal rnas | TAXON | 1 |
| anti sars cov 2 iga | ORG | 1 |
| anticontractile | CHEMICAL | 1 |
| antiphospholipid | DISEASE | 1 |
| antiplatelets | CHEMICAL | 1 |
| anxiety depression | DISEASE | 1 |
| apnoea | DISEASE | 1 |
| atherosclerotic vascular disease | DISEASE | 1 |
| appetite overeating | CHEMICAL | 1 |
| appetite regulating hormones and peptides such | CHEMICAL | 1 |
| apples pears cabbage carrots squashes sweet potatoes and beets gardening | CHEMICAL | 1 |
| arachidonic acid omega 6 | CHEMICAL | 1 |
| arrhythmia | DISEASE | 1 |
| arrhythmias | DISEASE | 1 |
| arterivirus rna polymerase | TAXON | 1 |
| ascorbic acid | CHEMICAL | 1 |
| asthma allergy atopic dermatitis | DISEASE | 1 |
| asthma chronic skin | DISEASE | 1 |
| atelectasis | DISEASE | 1 |
| atherosclerosis obesity | DISEASE | 1 |
| atherosclerosis diabetes hypertension | DISEASE | 1 |
| atherosclerotic lesion | DISEASE | 1 |
| cardiorespiratory diseases | DISEASE | 1 |
| cardiovascular alterations | DISEASE | 1 |
| coronary heart disease stroke | DISEASE | 1 |
| compression of morbidity | DISEASE | 1 |
| chronic rhinosinusitis sendai virus | DISEASE | 1 |
| circankrd36 | ORG | 1 |
| circrna rbp | ORG | 1 |
| circrna mirna | ORG | 1 |
| circznf609 | CHEMICAL | 1 |
| cirrhosis | DISEASE | 1 |
| cognitive disabilities | DISEASE | 1 |
| cognitive distortion | DISEASE | 1 |
| colds stomach problems | DISEASE | 1 |
| comorbid a p value 0 | DISEASE | 1 |
| comorbid diseases type 2 diabetes t2d ischemic heart disease hyperlipidemia sleep apnea | DISEASE | 1 |
| comorbidities chronic kidney and lung diseases malignancies diabetes obesity sickle cell anemia immune disorders chromosomal abnormalities heart disease | DISEASE | 1 |
| comorbidity increase | DISEASE | 1 |
| complexity | DISEASE | 1 |
| concurs | CHEMICAL | 1 |
| chronic inflammatory diseases | DISEASE | 1 |
| confusion | DISEASE | 1 |
| congenital anomaly | DISEASE | 1 |
| congenital malformations | DISEASE | 1 |
| contagion | DISEASE | 1 |
| cord 266380 lu6hj3a2 | DISEASE | 1 |
| cord 267505 | CHEMICAL | 1 |
| cord 290551 a02tueuu | DISEASE | 1 |
| cord 311535 | CHEMICAL | 1 |
| cord 318391 | CHEMICAL | 1 |
| cord 329308 | DISEASE | 1 |
| cord 338317 | DISEASE | 1 |
| cord 351223 | CHEMICAL | 1 |
| cord_uid ipui7lo6 | ORG | 1 |
| cord_uid stod75j2 objective obesity | ORG | 1 |
| chronic major comorbidity | DISEASE | 1 |
| chronic illness | DISEASE | 1 |
| cardiovascular and hepatic alterations | DISEASE | 1 |
| cardiovascular morbidity | DISEASE | 1 |
| cardiovascular and hepatic consequences | DISEASE | 1 |
| cardiovascular and liver health | DISEASE | 1 |
| cardiovascular and renal regulation angiotensin | DISEASE | 1 |
| cardiovascular complications | DISEASE | 1 |
| cardiovascular disease angiotensin | DISEASE | 1 |
| cardiovascular disease saturated fatty acid | DISEASE | 1 |
| cardiovascular disease diabetes | DISEASE | 1 |
| cardiovascular diseases cvd | DISEASE | 1 |
| cardiovascular diseases cvd diabetes hypertension | DISEASE | 1 |
| cardiovascular diseases diabetes | DISEASE | 1 |
| cardiovascular disorders | DISEASE | 1 |
| cardiovascular liver | DISEASE | 1 |
| cardiovascular manifestations acute cardiac injury | DISEASE | 1 |